{"id": "CD007431", "boolean": "(Back[mesh] OR spine[mesh] OR back[Title] OR lowback[Text Word] OR lumbar[Text Word] OR lumbal[Text Word] OR lumbo*[Text Word] OR sciatic[Text Word] OR spine[Text Word] OR spinal[Text Word] OR radicular[Text Word] OR \"nerve root\"[Text Word] OR \"nerve roots\"[Text Word] OR disk[Text Word] OR disc[Text Word] OR disks[Text Word] OR discs[Text Word] OR vertebra*[Text Word] OR intervertebra*[Text Word] OR sacroilia*[Text Word] OR Sacroiliac joint[mesh]) AND (Pain[mesh] OR pain[Text Word] OR ache*[Text Word] OR aching[Text Word] OR complaint*[Text Word] OR dysfunction*[Text Word] OR disabil*[Text Word] OR neuralgia[Text Word]) AND (\"straight leg raising\"[Text Word] OR lasegue[Text Word] OR \"bell test\"[Text Word] OR \"hyperextension test\"[Text Word] OR \"femoral nerve stretch test\"[Text Word] OR \"Reflex, stretch\"[mesh] OR slump[Text Word]) AND (Intervertebral disk displacement[mesh] OR polyradiculopathy[mesh] OR radiculopath*[All Fields] OR radiculiti*[All Fields]) AND (back pain[mesh] OR sciatica[mesh] OR \"back ache\"[Text Word] OR backache[Text Word] OR \"back pain\"[Text Word] OR dorsalgia[Text Word] OR lumbago[Text Word] OR sciatica[Text Word] OR ischias[Text Word] OR ischialgia[Text Word] OR lumboischialgia[Text Word] OR radiculalgia[Text Word]) AND (Physical examination[mesh] OR \"physical examination\"[All Fields] OR \"function test\"[All Fields] OR \"physical test\"[All Fields]) AND (Diagnostic errors[mesh] OR \"Diagnosis, differential\"[mesh] OR \"Reproducibility of results\"[mesh] OR Reference standards[mesh] OR \"Sensitivity and specificity\"[mesh] OR Comparative study[Publication Type] OR \"Evaluation Studies as Topic\"[mesh] OR Evaluation studies[Publication Type] OR Longitudinal studies[mesh] OR sensitivit*[All Fields] OR specificit*[All Fields] OR accura*[All Fields] OR likelihood ratio*[All Fields] OR predict*[All Fields] OR index test[All Fields] OR reference test[All Fields] OR pretest[Text Word] OR pre-test[Text Word] OR posttest[Text Word] OR post-test[Text Word] OR \"gold standard\"[All Fields] OR roc[Text Word] OR odds[Text Word] OR validity[All Fields] OR validation[All Fields] OR validate*[All Fields] OR validation studies[Publication Type] OR verif*[ti] OR evaluat*[ti] OR value*[ti] OR reference values[mesh] OR cutoff[All Fields] OR cut-off[All Fields] OR repeatability[All Fields] OR reproducibility[All Fields] OR efficacy[All Fields] OR reliability[All Fields] OR error*[Text Word] OR suitability[Text Word] OR utility[Text Word])", "generated_query": ["What are the most effective diagnostic tests or intervertebral disc displacement for identifying patients with complaints of back pain, dorsalgia, lumbago, dorsal muscle tissue, intervertebral discs, and nerve roots in studies on medical imaging, spinal injections, lasegue, and surgical procedures? Additionally, what are the most reliable and effective diagnostic tests or intervertebral disc displacement for identifying patients with complaints of back pain, dorsalgia, lumbago, dorsal muscle tissue, intervertebral discs, and nerve roots in studies on medical imaging, spinal injections, lasegue, and surgical procedures? Finally, what are the most effective diagnostic tests or intervertebral disc displacement for identifying patients with complaints of back pain, dorsalgia, lumbago, dorsal muscle tissue, intervertebral discs, and nerve roots in studies on medical imaging, spinal injections, lasegue, and surgical procedures?", "What is the effectiveness of diagnostic tests, such as those mentioned in the query, in identifying red flags for patients with complaints such as back pain, dorsalgia, lumbago, neuralgia, or disc problems, in patients with symptoms such as back pain, dorsalgia, lumbago, neuralgia, or disc problems? Additionally, what is the diagnostic accuracy of these tests, as compared to other tests, in identifying red flags for patients with complaints such as back pain, dorsalgia, lumbago, neuralgia, or disc problems, in patients with symptoms such as back pain, dorsalgia, lumbago, neuralgia, or disc problems?", "What is the diagnostic accuracy of intervertebral disc displacement, polyradiculopathy, radiculopathy, dorsalgia, lumbago, ischias, and other related conditions, as compared to patients with complaints of back pain, dysfunction, or disability? Please include studies such as the back, spine, intervertebral disc, and sacroiliac joint in your search. Additionally, what are the most effective diagnostic tests, including strait leg raising, lasegue, and bell test, for identifying these conditions in patients with complaints of dorsalgia, lumbago, or ischias? Finally, what are the sensitivity, specificity, likelihood ratios, and validity values for these tests?", "What is the diagnostic accuracy of intervertebral discs, lumbar discs, and sacroiliac joints in patients with complaints such as back pain, dorsalgia, lumbago, neurogia, and sciatica? The search should also include studies on the accuracy of physical examination tests such as the Reflex, Stretch, and Sump tests, as well as diagnostic tests such as the Bell test, hyperextension test, and femoral nerve stretch test. Additionally, search terms such as diagnostic errors, sensitivity, specificity, likelihood ratios, and odds ratios should be utilized in order to assess the value of these tests in patients with complaints such as back pain, dorsalgia, lumbago, neurogia, and sciatica? Finally, what are the characteristics of these tests, including accuracy, diagnostic errors, sensitivity, specificity, likelihood ratios, and odds ratios, in patients with complaints such as back pain, dorsalgia, lumbago, neurogia, and sciatica?", "What are the most effective diagnostic tests and physical examination maneuvers for identifying patients with complaints of back pain, dorsalgia, lumbago, dorsal or back pain, or intervertebral disc displacement? Additionally, what are the most reliable and effective diagnostic tests and physical examination maneuvers for identifying these patients and differentiating them from patients with complaints of headache, neck pain, or chest pain? Finally, what are the most accurate and reliable diagnostic tests and physical examination maneuvers for identifying patients with complaints of back pain, dorsalgia, lumbago, or disc displacement, and what are the most appropriate and effective treatments for these patients?", "What is the effectiveness of diagnostic tests, such as those for detecting intervertebral disc displacement, polyradiculopathy, and disc injuries, in patients with complaints of back pain, dorsalgia, lumbago, neuralgia, or other related symptoms? Additionally, what is the effectiveness of therapeutic interventions, including lasegue, bell test, hyperextension test, and straigh leg raising, in patients with diagnostic errors, pretest values, posttest values, likelihood ratios, and predictive values? Finally, what is the diagnostic accuracy, sensitivity, specificity, validity, validity, likelihood ratio, and predictive value of these tests in identifying patients with complaints of back pain, dorsalgia, lumbago, neuralgia, or other related symptoms?", "What is the diagnostic accuracy of physical examination and imaging tests such as MRI, CT, and ultrasound in detecting intervertebral disk displacement, polyradiculopathy, and neurological conditions such as dorsalgia, lumbago, and sciatica in patients with complaints such as back pain, dorsa, lumb, and neck pain? Additionally, what are the most effective diagnostic tests and examinations for identifying these conditions and their associated symptoms, such as the straight leg raising, lasegue, and bell test, as compared to other tests such as CT, MRI, and ultrasound, while maintaining sensitivity and specificity?", "What is the diagnostic accuracy of intervertebral disc displacement, polyradiculopathy, and radiculopathy, including sciatica, dorsalgia, lumbago, and neuralgia, in patients with complaints of back pain, dorsal or lumbar pain, and nerve roots? The search should also include related tests such as the lasegue, bell test, hyperextension test, and femoral nerve stretch test, as well as studies on the diagnostic accuracy of physiotherapy and other treatments for these conditions.", "What are the most effective diagnostic tests and physical examination procedures for identifying red flags for intervertebral disk displacement, polyradiculopathy, and radiculitis in patients with complaints of dorsalgia, lumbago, neurological symptoms, muscular injuries, and spinal stenosis, as compared to placebo or other treatments? Specifically, I am looking for studies that utilize the following diagnostic tests and physical examination procedures: straight leg raising, lasegue, bell test, hyperextension test, femoral nerve stretch test, Reflex, slump, intervertebral disc displacement, polyradiculopathy, radiculopathy, and dorsalgia? Please also include any studies that investigate the diagnostic accuracy, value, or reliability of these tests, as well as any studies that investigate the sensitivity, specificity, likelihood ratios, or area under the ROC curve of these tests.", "What is the diagnostic accuracy and reliability of various nerve and disk tests, including back pain, dorsalgia, lumbago, and sciatica, in patients with complaints of ache, dysfunction, or disability?"]}
{"id": "CD008803", "boolean": "(glaucoma[mesh] OR ocular hypertension[mesh] OR optic nerve diseases[mesh:noexp] OR optic disk[mesh:noexp] OR retinal ganglion cells[mesh:noexp] OR glaucoma*[Text Word] OR RNFL[Text Word] OR optic dis*[Text Word] OR retinal ganglion cell*[Text Word] OR ONH[Text Word] OR (retinal[Text Word] AND nerve[Text Word] AND fiber[Text Word] AND layer[Text Word]) OR (pressure[Text Word] AND ((increas*[Text Word] OR elevat*[Text Word] OR high*[Text Word] OR raise*[Text Word]) AND (ocular[Text Word] OR intraocular[Text Word] OR intra-ocular[Text Word]))) OR (retinal[Text Word] AND nerve[Text Word] AND fibre[Text Word] AND layer[Text Word]) OR (optic[Text Word] AND nerve*[Text Word] AND head[Text Word]) OR (OHT[Text Word] OR IOP[Text Word])) AND (ophthalmoscopy[mesh:noexp] OR Lasers[mesh:noexp] OR tomography, optical coherence[mesh:noexp] OR tomography, optical[mesh:noexp] OR enhanced corneal compensat*[Text Word] OR variable corneal compensat*[Text Word] OR OCT[Title/Abstract] OR GDx[Text Word] OR HRT[Title/Abstract] OR SLP[Text Word] OR VCC[Text Word] OR (optical[Text Word] AND coherence[Text Word] AND interferomet*[Text Word]) OR (Heidelberg[Text Word] AND Retina[Text Word] AND Tomograph*[Text Word]) OR (scan*[Text Word] AND laser*[Text Word] AND polarimetry[Text Word]) OR (confocal[Text Word] AND scan*[Text Word] AND laser[Text Word] AND ophthalm*[Text Word]) OR (optical[Text Word] AND coherence[Text Word] AND tomograph*[Text Word]))", "generated_query": ["What is the effectiveness of ophthalmoscopy, lasers, tomography, optical coherence, OCT, GDx, HRT, SLP, VCC, and optical interferometry in detecting glaucoma, ocular hypertension, and optic nerve diseases such as retinal ganglion cells, optic disks, and retinal nerve fibres?", "What is the effectiveness of ophthalmoscopy, lasers, tomography, optical coherence, OCT, GDx, HRT, SLP, VCC, optical coherence, and Heidelberg retina-tomography in detecting glaucoma, ocular hypertension, optic nerve diseases, and retinal ganglion cells in patients with conditions such as ONH, retinal, nerve, and fibre?", "What is the effectiveness of treatments for glaucoma, ocular hypertension, optic nerve diseases, optic disk, retinal ganglion cells, ONH, retina, and ocular tissues, as evaluated in studies involving ophthalmoscopy, lasers, tomography, optical coherence, OCT, GDx, HRT, SLP, VCC, and optical coherence tomography?", "What is the effectiveness of ophthalmic imaging techniques, such as tomography, optical coherence, and enhanced corneal compensation, in the diagnosis and management of glaucoma, ocular hypertension, and optic nerve diseases?", "What is the effectiveness of glaucoma, ocular hypertension, and optic nerve diseases in patients undergoing ophthalmoscopy, Lasers, tomography, optical coherence, and enhanced corneal compensation?", "What is the diagnostic accuracy of ophthalmoscopy, lasers, tomography, optical coherence, enhanced corneal compensation, variable corneal compensation, and optical coherence tomography in detecting glaucoma, ocular hypertension, optic nerve diseases, and optic disks in patients with retinal ganglion cells, ONH, retinal nerve fibers, or pressure-driven dilation of the pupils?", "What is the diagnostic accuracy of ophthalmoscopy, lasers, and optical coherence tomography in detecting glaucoma, ocular hypertension, and optic nerve diseases such as ONH, retinal nerve, and retinal ganglion cells?", "What is the effectiveness of ophthalmoscopy, lasers, and tomography, optical coherence, in detecting glaucoma, ocular hypertension, and optic nerve diseases, such as retinal ganglion cells, ONH, retinal, and nerve fibers, in patients with conditions such as myopia, nearsightedness, and farsightedness? Additionally, does the use of these diagnostic tests impact the development or progression of glaucoma, ocular hypertension, or optic nerve diseases?", "What is the effectiveness of ophthalmoscopy, lasers, tomography, optical coherence, and other imaging modalities in detecting glaucoma, ocular hypertension, optic nerve diseases, optic disk, retinal ganglion cells, ONH, retinal, and nerve fibres in patients with elevated intraocular pressure?", "What is the effectiveness of diagnostic tests, such as Ophthalmoscopy, Lasers, and Optical Coherence Tomography, in detecting glaucoma, ocular hypertension, optic nerve diseases, optic disk, retinal ganglion cells, and ONH in patients with mild to severe vision loss?"]}
{"id": "CD008782", "boolean": "(Dementia[mesh] OR Cognition Disorders[mesh:noexp] OR Neurofibrils[mesh] OR Neurofilament Proteins[mesh:noexp] OR Senile Plaques[mesh:noexp] OR Neuropil Threads[mesh:noexp] OR MCI[Title/Abstract] OR SMC[Title/Abstract] OR LCD[Title/Abstract] OR AACD[Title/Abstract] OR MCD[Title/Abstract] OR ACMI[Title/Abstract] OR ARCD[Title/Abstract] OR AAMI[Title/Abstract] OR MD[Title/Abstract] OR MNCD[Title/Abstract] OR CIND[Title/Abstract] OR QD[Title/Abstract] OR BSF[Title/Abstract] OR (alzheimer*[Title/Abstract] OR dement*[Title/Abstract]) OR ((cognit*[Title/Abstract] OR memory[Title/Abstract] OR cerebr*[Title/Abstract] OR mental*[Title/Abstract]) AND (declin*[Title/Abstract] OR impair*[Title/Abstract] OR los*[Title/Abstract] OR deteriorat*[Title/Abstract] OR degenerat*[Title/Abstract] OR complain*[Title/Abstract] OR disturb*[Title/Abstract] OR disorder*[Title/Abstract])) OR (neurofilament[Title/Abstract] AND protein*[Title/Abstract]) OR (plaque*[Title/Abstract] AND (senile[Title/Abstract] OR amyloid[Title/Abstract] OR neuritic[Title/Abstract])) OR (neuropil[Title/Abstract] AND thread*[Title/Abstract]) OR (forgetful*[Title/Abstract] OR confused[Title/Abstract] OR confusion[Title/Abstract]) OR (neurofibril*[Title/Abstract] AND tangle*[Title/Abstract])) AND (Cerebrospinal Fluid[mesh:noexp] OR Blood-Brain Barrier[mesh:noexp] OR (cerebrospinal fluid*[Title/Abstract] OR csf[Title/Abstract] OR spinal fluid*[Title/Abstract]) OR (blood[Title/Abstract] OR plasma[Title/Abstract])) AND (Amyloid Beta-Protein[mesh] OR Peptide Fragments[mesh:noexp] OR ABPP[Title/Abstract] OR APP[Title/Abstract] OR beta*[Title/Abstract] OR Abeta*[Title/Abstract] OR amyloid[Title/Abstract] OR (beta[Title/Abstract] AND A4[Title/Abstract]) OR (amyloidogenic[Title/Abstract] AND (peptide*[Title/Abstract] OR protein*[Title/Abstract])) OR (Innotest[Title/Abstract] OR Inno-bia[Title/Abstract] OR Alzbio3[Title/Abstract]))", "generated_query": ["What is the effectiveness of diagnostic tests, such as those for dementia, cognition disorders, neurofibrils, neurofilament proteins, senile plaques, neuropil threads, MCI, SMC, LCD, AACD, MCD, ACMI, ARCD, AAMI, MD, MNCD, CIND, QD, BSF, alzheimer, dement, cognitive decline, impairment, loss, deterioration, complaints, disturbances, disorders, neurofilament tangle, CSF, plasma, blood, and amyloid beta-protein on detecting Alzheimer's disease? Additionally, what is the effectiveness of diagnostic tests, such as those for dementia, cognition disorders, neurofibrils, neurofilament proteins, senile plaques, neuropil threads, MCI, SMC, LCD, AACD, MCD, ACMI, ARCD, AAMI, MD, MNCD, CIND, QD, BSF, alzheimer, dement, cognitive decline, imp", "What is the effectiveness of diagnostic tests, such as those for Alzheimer's disease, neurofibrils, and amyloid beta-protein, in identifying neurodegenerative conditions such as cognitive decline, dementia, and Alzheimer's disease, and their associated features such as senile plaques, neuropil threads, and MCI?", "What is the effectiveness of biomarkers such as Dementia, Cognition Disorders, Neurofibrils, neurofilament proteins, senile plaques, neuropil threads, MCI, SMC, LCD, AACD, and MCD in identifying Alzheimer's disease and other related disorders? Additionally, what is the effectiveness of markers such as amyloid beta-protein, peptide fragments, and ABPP in detecting Alzheimer's disease, and what is the accuracy and reliability of tests such as Innotest, Inno-bia, Alzbio3, and amyloidogenic in detecting amyloid plaques, neurofibrils, neurofilament proteins, and senile plaques?", "What is the effectiveness of diagnostic tests, such as those for detecting Alzheimer's disease and cognitive decline, in identifying neurofibrils, neurofilament proteins, and senile plaques, as compared to controls, in cerebrospinal fluid and blood-brain barrier samples?", "What is the effectiveness of diagnostic tests such as the Cerebrospinal Fluid Test, Blood-Brain Barrier Test, and Innotest in detecting dementia, cognition disorders, neurofibrils, neurofilament proteins, senile plaques, neuropil threads, MCI, SMC, LCD, AACD, MCD, ACMI, ARCD, AAMI, MD, MNCD, CIND, QD, BSF, Alzheimer, dementia, cognitive decline, and other related conditions in patients with symptoms such as memory loss, cerebral death, mental impairment, decreased sensation, deterioration, and complain?", "What is the effectiveness of diagnostic tests, such as Dementia, Cognition Disorders, Neurofibrils, Neurofilament proteins, Senile Plaques, Neuropil Threads, and MCI, in detecting Alzheimer's disease?", "What is the effectiveness of diagnostic tests, such as those for detecting dementia, cognition disorders, neurofibrils, neurofilament proteins, senile plaques, neuropil threads, and MCI, in patients with complaints of forgetfulness, confusion, deterioration, and impairments? Additionally, what is the accuracy of tests such as those for detecting AACD, MCD, ACMI, ARCD, AAMI, MD, MNCD, CIND, QD, BSF, alzheimer, and dementia, and what are the characteristics of these tests?", "What is the effectiveness of diagnostic tests, including the Innotest, in identifying and characterizing neurofibrils, neurofilament proteins, senile plaques, neuropil threads, MCI, SMC, LCD, AACD, and MCD in cerebrospinal fluid, blood-brain barrier, and amyloid beta-protein levels?", "What is the effectiveness of diagnostic imaging, including CT, MRI, and ultrasound, in detecting dementia, cognition disorders, neurofibrils, neurofilament proteins, senile plaques, neuropil threads, and MCI in elderly patients? Additionally, what is the effectiveness of amyloid imaging agents such as AMYVILLE, SAMYVIL, and FP-16 in detecting Alzheimer's disease, amyloid plaques, and neurodegeneration, and what is the diagnostic accuracy of the Innotest, Inno-bia, Alzbio3, and AACD in detecting Alzheimer's disease and amyloid imaging agents?", "What is the effectiveness of diagnostic tests, including neurofibrils, neurofilament proteins, senile plaques, neuropil threads, MCI, SMC, LCD, AACD, MCD, ACMI, ARCD, AAMI, MD, MNCD, CIND, QD, BSF, and Alzheimer's disease in detecting cognitive disorders, neurofibrils, neurofilament proteins, senile plaques, neuropil threads, MCI, SMC, LCD, AACD, MCD, ACMI, ARCD, AAMI, MD, MNCD, CIND, QD, BSF, and Alzheimer's disease in patients with complaints of forgetfulness, confusion, deterioration, disturbances, disorders, or decline?"]}
{"id": "CD009647", "boolean": "(Electric Impedance[mesh:noexp] OR Body Temperature Regulation[mesh:noexp] OR Sweating[mesh:noexp] OR Thermogenesis[mesh:noexp] OR Body Weight Changes[mesh:noexp] OR Weight Loss[mesh:noexp] OR Physical Examination[mesh:noexp] OR Skin Temperature[mesh:noexp] OR Plethysmography, Impedance[mesh:noexp] OR Water Loss, Insensible[mesh:noexp] OR (Upper Extremity[mesh:noexp] OR Arm[mesh:noexp] AND Muscle Weakness[mesh:noexp]) OR ((thermal[Text Word] OR temperature*[Text Word]) AND (regulat*[Text Word] OR control*[Text Word])) OR (blood flow*[Text Word] AND (skin[Text Word] OR epiderm*[Text Word] OR dermal[Text Word])) OR ((clinical*[Text Word] OR physical[Text Word]) AND (sign*[Text Word] OR symptom*[Text Word] OR exam*[Text Word] OR finding*[Text Word] OR assess*[Text Word])) OR ((weak[Text Word] OR weakness[Text Word]) AND (arm*[Text Word] OR upper limb*[Text Word] OR upper extremit*[Text Word])) OR ((fluid*[Text Word] OR water[Text Word]) AND (balance[Text Word] OR chart*[Text Word] OR record*[Text Word] OR diary[Text Word] OR diaries[Text Word])) OR ((weight[Text Word] OR BMI[Text Word] OR body mass index[Text Word]) AND (loss[Text Word] OR lost[Text Word] OR lose[Text Word] OR losing[Text Word] OR fall*[Text Word] OR reduc*[Text Word] OR chang*[Text Word])) OR (capillar*[Text Word] AND refill*[Text Word]) OR ((epiderm*[Text Word] OR skin*[Text Word] OR transepiderm*[Text Word] OR transderm*[Text Word]) AND (water*[Text Word] OR fluid*[Text Word] OR temperature[Text Word])) OR (thermoregulat*[Text Word] OR thermogenesis[Text Word] OR sweating[Text Word]) OR (impedance*[Text Word] OR bioimpedance[Text Word] OR BIA[Text Word])) AND (Aged[mesh] OR \"65 and over\"[Text Word] OR sixty five years[Text Word] OR nursing home*[Text Word] OR care home*[Text Word] OR aged[Text Word] OR elder*[Text Word] OR \"sixty five and over\"[Text Word] OR old age[Text Word] OR (geriatric[Text Word] OR geriatrics[Text Word]) OR (senile[Text Word] OR senility[Text Word]) OR (older adult*[Text Word] OR older people[Text Word] OR older person*[Text Word] OR older patient*[Text Word] OR older women[Text Word] OR older men[Text Word])) AND (Eye[mesh] OR eye[Text Word] OR eyes[Text Word]) AND (Skin[mesh:noexp] OR Mucous Membrane[mesh:noexp] OR Nasal Mucosa[mesh] OR Respiratory Mucosa[mesh:noexp] OR Tongue[mesh:noexp] OR Axilla[mesh:noexp] OR Mouth Mucosa[mesh:noexp] OR (tongue*[Text Word] OR axilla*[Text Word] OR armpit*[Text Word] OR skin[Text Word]) OR (mucous membrane*[Text Word] OR mucosal tissue*[Text Word] OR mucosa[Text Word])) AND (Hyponatremia[mesh:noexp] OR Dehydration[mesh:noexp] OR Hypokalemia[mesh:noexp] OR Osmolar Concentration[mesh:noexp] OR Water-electrolyte Imbalance[mesh:noexp] OR Water-electrolyte Balance[mesh:noexp] OR Hypernatremia[mesh:noexp] OR Hypovolemia[mesh:noexp] OR h*[Text Word] OR osmolalit*[Text Word] OR hypovol*[Text Word] OR (dehydrat*[Text Word] OR hydrat*[Text Word]) OR ((fluid*[Text Word] OR water[Text Word]) AND (balance*[Text Word] OR imbalance*[Text Word] OR status[Text Word] OR body[Text Word] OR extracellular[Text Word] OR intracellular[Text Word])) OR (plasma*[Text Word] AND (tonicit*[Text Word] OR hypertonic*[Text Word] OR hypotonic*[Text Word])) OR (hypokal*[Text Word] OR hyperkal*[Text Word] OR hyponatr*[Text Word] OR hypernatr*[Text Word])) AND (Blood Pressure[mesh] OR Dizziness[mesh:noexp] OR Urine[mesh:noexp] OR Pulse[mesh:noexp] OR Heart Rate[mesh:noexp] OR ((pulse[Text Word] OR heart[Text Word]) AND (rapid*[Text Word] OR change*[Text Word] OR fast[Text Word])) OR (urin*[Text Word] AND (volume*[Text Word] OR colo*[Text Word] OR dark*[Text Word] OR gravit*[Text Word] OR concentration[Text Word])) OR (pressure*[Text Word] AND (systolic[Text Word] OR diastolic[Text Word])) OR (dizz*[Text Word] OR lightheaded*[Text Word] OR orthostasis[Text Word]))", "generated_query": ["What is the impact of body temperature regulation, sweating, and therapeutic interventions on the development or progression of hyponatremia, dehydration, and osmolarity in patients with conditions such as chronic disease, aged 65 and over, nursing home patients, and patients in care homes?", "What is the effectiveness of diagnostic tests, including electrochemical impedance, body temperature regulation, sweating, and physical examination, in identifying the cause of hypovolemia, hematologic and metabolic derangements, and other related conditions in patients undergoing medical care in nursing homes, care homes, aged care homes, and rehabilitation centers?", "What is the effectiveness of electric impulses, body temperature regulation, and other non-invasive medical tests in detecting age-related conditions such as hyponatremia, dehydration, and hypothermia in older adults, 65 and over, and those in nursing homes?", "What is the effectiveness of body temperature regulation, skin temperature, and urinary output in detecting medical conditions such as hypovolemia, hyponatremia, and urinary infections in patients aged 65 and over?", "What is the effectiveness of medical interventions, including electrical impedance, body temperature regulation, sweating, thermogenesis, and blood pressure control, in treating conditions such as urinary infections, dizziness, and orthostasis in elderly patients? Additionally, what are the clinical findings, assessments, and diaries of these patients, and what is the impact of these findings on the development of medical interventions?", "What is the effectiveness of interventions for managing electrolyte and water balance disorders, including medication and dietary changes, in patients with conditions such as diabetes, hypertension, and hyperlipidemia?", "What is the effectiveness of electric impulse therapy, body temperature regulation, sweating, and insensible water loss in treating conditions such as nursing home patients, elderly individuals, and aged adults? Please include studies on eye health, mucous membrane health, and urinary tract infections in your search.", "What is the effectiveness of using electric impedance, body temperature regulation, sweating, thermogenesis, body weight changes, water loss, upper extremity, and arm muscles in patients aged 65 and over, including those in nursing homes and care homes? Specifically, I am interested in studies that investigate the relationship between these parameters and conditions such as urinary incontinence, dizziness, and cardiovascular disease?", "What is the effectiveness of electroimpedance and body temperature regulation in detecting and monitoring urinary and cardiovascular disease in elderly patients in nursing homes, care homes, or aged individuals? Specifically, I am interested in studies that investigate the use of these devices in detecting urinary infections such as UTI, cystitis, pyelitis, nephritis, and interstitial nephritis, as well as studies that investigate the use of these devices in detecting cardiovascular disease such as heart disease, coronary heart disease, and stroke? Additionally, I am also interested in studies that investigate the use of these devices in detecting muscle weakness, fluid imbalance, electrolyte imbalance, and hyponatremia in patients in these care facilities?", "What is the effectiveness of using electrodes, body temperature monitors, and other devices in detecting and monitoring changes in blood pressure, dizziness, urine, and pulse in patients aged 65 and over, nursing home patients, and elderly individuals?"]}
{"id": "CD009135", "boolean": "(Leishmaniasis, visceral[mesh] OR Leishmania donovani[mesh] OR Leishmania infantum[mesh] OR Leishmania chagasi[Title/Abstract] OR Visceral leishmania*[Title/Abstract] OR kala-azar[Title/Abstract]) AND (Immunoblotting[mesh:noexp] OR Latex Fixation Tests[mesh:noexp] OR Serological tests[mesh:noexp] OR Enzyme-Linked Immunosorbent Assay[mesh:noexp] OR Reagent kits, diagnostic[mesh:noexp] OR Serodiagnostic test*[Title/Abstract] OR ELISA[Title/Abstract] OR \"K39 antigen, Leishmania\"[All Fields] OR K39 Or rK39[Title/Abstract] OR RDT[Title/Abstract] OR Antigen*[Title/Abstract] OR Lateral flow test[Title/Abstract] OR Strip test*[Title/Abstract] OR Rapid diagnostic test*[Title/Abstract] OR Antibod*[Title/Abstract] OR Direct agglutination test*[Title/Abstract] OR Dipstick*[Title/Abstract] OR \"K26 antigen, Leishmania\"[All Fields])", "generated_query": ["What is the diagnostic accuracy of immunoblotting, latex fixation tests, serological tests, enzyme-linked immunosorbent assay, reagent kits, diagnostic, serodiagnostic tests, and immunization kits for detecting leishmaniasis, including kala-azar, caused by Leishmania donovani, Leishmania infantum, Leishmania chagasi, or visceral leishmania?", "What is the diagnostic accuracy of immunoblotting, latex fixation tests, and serological tests in detecting leishmaniasis, including kala-azar, chagasi, and donovani, as well as specific antigen markers such as K39, rK39, and DT, in patients with symptoms suggestive of leishmaniasis?", "What is the diagnostic accuracy of immunoblotting, latex fixation tests, serological tests, enzyme-linked immunosorbent assay, reagent kits, diagnostic, serodiagnostic tests, ELISA, K39 antigen, Leishmania, kala-azar, and other diagnostic tests for detecting leishmaniasis, including antibodies, direct agglutination, dipsticks, K26 antigen, and latex fixation tests?", "What is the diagnostic accuracy of immunoblotting, latex fixation tests, serological tests, enzyme-linked immunosorbent assay, reagent kits, diagnostic, serodiagnostic tests, ELISA, K39 antigen, Leishmania, and other diagnostic tests for detecting leishmaniasis, including kala-azar, and identifying the causative agent, Leishmania donovani, or one of its variants, such as Leishmania infantum, or other related species, such as Leishmania chagasi?", "What are the most effective immunodiagnostic tests for detecting leishmaniasis, including Immunoblotting, Latex Fixation Tests, Serological tests, Enzyme-Linked Immunosorbent Assay, Reagent kits, diagnostic, Serodiagnostic tests, ELISA, K39 antigen, Leishmania, K39, rK39, RDT, antigen, lateral flow tests, strip tests, rapid diagnostic tests, antibodies, direct agglutination tests, dipsticks, K26 antigen, and reagent kits, diagnostic, for detecting leishmaniasis?", "What is the diagnostic accuracy of immunoblotting, latex fixation tests, serological tests, enzyme-linked immunosorbent assay, reagent kits, diagnostic, serodiagnostic tests, ELISA, K39 antigen, Leishmania, and rapid diagnostic tests in detecting leishmaniasis, including kala-azar, infantum, chagasi, and visceral leishmania?", "What are the most effective diagnostic tests for detecting leishmaniasis, including immunoblotting, latex fixation tests, serological tests, enzyme-linked immunosorbent assay, reagent kits, diagnostic, serodiagnostic test, ELISA, K39 antigen, leishmania, kala-azar, immunoblotting, latex fixation tests, serological tests, enzyme-linked immunosorbent assay, reagent kits, diagnostic, serodiagnostic test, ELISA, K39 antigen, leishmania, kala-azar, immunoblotting, latex fixation tests, serological tests, enzyme-linked immunosorbent assay, reagent kits, diagnostic, serodiagnostic test, ELISA, K39 antigen, leishmania, kala-azar, immunoblotting, latex fixation tests, serological tests, enzyme-linked immunosorbent assay, reagent kits, diagnostic, serodiagnostic test, ELISA, K39 antigen, leishmania", "What are the diagnostic tests, including immunoblotting, latex fixation tests, serological tests, enzyme-linked immunosorbent assay, reagent kits, diagnostic, serodiagnostic tests, Enzyme-Linked Immunosorbent Assay, RDT, antigen, lateral flow tests, stipe tests, and rapid diagnostic tests, that detect leishmaniasis, visceral, including kala-azar, chagasi, infantum, and donovani?", "What is the diagnostic accuracy of immunoblotting, latex fixation tests, serological tests, enzyme-linked immunosorbent assay, reagent kits, diagnostic tests, latex fixation tests, immunoblotting, K39 antigen, latex fixation tests, serological tests, enzyme-linked immunosorbent assay, reagent kits, diagnostic tests, latex fixation tests, immunoblotting, K26 antigen, latex fixation tests, serological tests, enzyme-linked immunosorbent assay, reagent kits, diagnostic tests, latex fixation tests, immunoblotting, K39 antigen, latex fixation tests, serological tests, enzyme-linked immunosorbent assay, reagent kits, diagnostic tests, latex fixation tests, immunoblotting, K26 antigen, latex fixation tests, serological tests, enzyme-linked immunosorbent assay, reagent kits, diagnostic tests, latex fixation tests, immunoblotting", "What is the diagnostic accuracy of immunoblotting, latex fixation tests, serological tests, enzyme-linked immunosorbent assay, reagent kits, diagnostic, serodiagnostic tests, ELISA, K39 antigen, Leishmania, and latex fixation tests for detecting leishmaniasis, visceral, including Kala-azar, in humans?"]}
{"id": "CD008760", "boolean": "(\"Esophageal and Gastric Varices\"[mesh:noexp] OR esophag* varic*[All Fields] OR esophag* varix[All Fields] OR esophago gastric varic*[All Fields] OR esophago gastric varix[All Fields] OR gastro esophag* varic*[All Fields] OR gastro esophag* varix[All Fields] OR gastro oesophag* varic*[All Fields] OR gastro oesophag* varix[All Fields] OR gastroesophag* varic*[All Fields] OR gastroesophag* varix[All Fields] OR gastrooesophag* varic*[All Fields] OR gastrooesophag* varix[All Fields] OR oesophag* varic*[All Fields] OR oesophag* varix[All Fields] OR oesophago gastric varic*[All Fields] OR oesophago gastric varix[All Fields] OR paraesophag* varic*[All Fields] OR paraesophag* varix[All Fields] OR paraoesophag* varic*[All Fields] OR paraoesophag* varix[All Fields] OR periesophag* varic*[All Fields] OR periesophag* varix[All Fields] OR perioesophag* varic*[All Fields] OR perioesophag* varix[All Fields])", "generated_query": ["What is the diagnostic accuracy of esophageal and gastric varices, as well as other imaging and endosonography techniques, in detecting and managing conditions such as liver disease, hepatitis, portal hypertension, and necrosis?", "What is the effectiveness of interventions for esophageal and gastric varices, including surgical procedures such as endovascular treatments, laparoscopic surgical procedures, and transcatheter procedures, as compared to placebo or other treatments, in reducing the morbidity and mortality in patients with conditions such as hepato-renal disease, hypertension, diabetes, and chronic kidney disease?", "What is the effectiveness of interventions for esophageal and gastric varices, including surgical procedures such as esophageal and gastric bypass, and endovascular procedures such as pancreaticojejunostomy, in managing conditions such as ulcers, gastritis, gastrostomy, and pancreatitisis?", "What is the effectiveness of interventions for esophageal and gastric varices, including surgical and endovascular procedures, as well as drug therapies such as vasoactive drugs and endoplasmic reticulum, in treating conditions such as ulcers, ulcer infections, and ulcer ulcer ulcer?", "What is the effectiveness of interventional procedures, including embolization, surgical interventions, endosonography, and ultrasonography, in patients with esophageal or gastric varices?", "What is the effectiveness of treatments for esophageal and gastric varices, including medical and surgical interventions, as compared to placebo or other treatments, in reducing morbidity and mortality in patients with conditions such as hepatic failure, liver disease, cardiomyopathy, and renal failure?", "What is the effectiveness of endovascular treatments such as stenting, coiling, and ballooning in managing esophageal and gastric varices, as well as ultrathin walled ulcers, ultrathin walled ultrast, and ultrathin walled ultrast?", "What is the effectiveness of interventions for esophageal and gastric varices, including endosonography, laser therapy, electrochemotherapy, and surgical procedures, such as Nissen Fundoplication, in treating these conditions?", "What is the effectiveness of endovascular treatments such as stents, shunts, and embolizations in managing esophageal and gastric varices, as well as other associated conditions such as ulcers and ulcerative conditions, in patients with conditions such as hypertension, cardiac disease, and diabetes?", "What is the effectiveness of interventions for esophageal and gastric varices, including surgical procedures such as EVT and SBP, as compared to placebo or other treatments, in reducing morbidity and mortality in patients with conditions such as ulcers, ulcer ulcers, ulcers, ulcers, ulcers, ulcers, ulcers, ulcers, ulcers, ulcers, ulcers, ulcers, ulcers, ulcers, ulcers, ulcers, ulcers, ulcers, ulcers, ulcers, ulcers, ulcers, ulcers, ulcers, ulcers, ulcers, ulcers, ulcers, ulcers, ulcers, ulcers, ulcers, ulcers, ulcers, ulcers, ulcers, ulcers, ulcers, ulcers, ulcers, ulcers, ulcers, ulcers, ulcers, ulcers, ulcers, ulcers, ulcers, ulcers, ulcers, ulcers, ulcers, ulcers, ulcers, ulcers, ulcers, ulcers, ulcers, ulcers, ulcers, ulcers, ulcers, ulcers, ulcers, ulcers,"]}
{"id": "CD010775", "boolean": "\"montreal cognitive assessment*\"[all fields] OR \"MoCA\"[all fields]", "generated_query": ["What is the effectiveness of the Montreal Cognitive Assessment (MoCA) in identifying mild cognitive impairment (MCI), Alzheimer's disease, and dementia in elderly individuals?", "What is the effectiveness of the Montreal Cognitive Assessment (MoCA) in identifying cognitive impairments, including those of memory, orientation, language, and executive function, in individuals with complaints of confusion, dizziness, blurred vision, or other related symptoms?", "What is the effectiveness of the Montreal Cognitive Assessment (MoCA) in identifying mild cognitive impairment, including Alzheimer's disease, and in patients with complaints of memory loss, confusion, and other cognitive decline?", "What is the effectiveness of the Montreal Cognitive Assessment (MoCA) in screening for mild cognitive impairment and dementia, as well as other related tests such as the Memory Impairment Screen, in patients with complaints suggestive of cognitive decline, including complaints of difficulty with memory, confusion, and disorientation?", "What is the effectiveness of the Montreal Cognitive Assessment in identifying mild cognitive impairment or Alzheimer's disease in older adults, as compared to other screening tests, such as those for depression, anxiety, and sleep quality?", "What is the effectiveness of the Montreal Cognitive Assessment (MoCA) in identifying mild cognitive impairment (MCI) in patients with symptoms suggestive of Alzheimer's disease, and how do changes in MoCA scores over time relate to the development or progression of MCI?", "What is the effectiveness of the Montreal Cognitive Assessment in identifying and managing patients with cognitive impairment or dementia, as compared to other screening tests such as those for Alzheimer's disease, in patients with complaints suggestive of cognitive impairment, such as forgetfulness, confusion, and disorientation?", "What is the effectiveness of the Montreal Cognitive Assessment (MoCA) in identifying and diagnosing cognitive impairment, including Alzheimer's disease, in elderly individuals?", "What is the effectiveness of the Montreal Cognitive Assessment in screening for mild cognitive impairment, Alzheimer's disease, and other related disorders?", "What is the effectiveness of the Montreal Cognitive Assessment (MoCA) in identifying mild cognitive impairment (MCI) and Alzheimer's disease in patients with complaints suggestive of cognitive decline, as compared to other screening tests, in studies that involve a population with a wide range of education levels?"]}
{"id": "CD009519", "boolean": "(Lung Neoplasms[mesh] OR NSCLC[Title/Abstract] OR ((lung[Title/Abstract] OR lungs[Title/Abstract] OR pulmonary[Title/Abstract]) AND (neoplasm*[Title/Abstract] OR cancer*[Title/Abstract] OR carcinoma*[Title/Abstract] OR adenocarcinoma*[Title/Abstract] OR angiosarcoma*[Title/Abstract] OR chrondosarcoma*[Title/Abstract] OR sarcoma*[Title/Abstract] OR teratoma*[Title/Abstract] OR lymphoma*[Title/Abstract] OR blastoma*[Title/Abstract] OR microcytic*[Title/Abstract] OR tumour*[Title/Abstract] OR tumor*[Title/Abstract]))) AND (Tomography[mesh:noexp] OR Tomography, Emission-Computed[mesh:noexp] OR Positron-Emission Tomography[mesh:noexp] OR Tomography, Spiral Computed[mesh:noexp] OR Fluorodeoxyglucose F18[mesh:noexp] OR (FDG[Text Word] OR Fludeoxyglucose[Text Word] OR fluorodeoxyglucose[Text Word] OR depreotide[Text Word]) OR ((positron[Text Word] OR photon[Text Word] OR scintillation[Text Word]) AND (emission[Text Word] OR tomograph*[Text Word])) OR (CGC[Text Word] OR PET[Text Word] OR SPECT[Text Word] OR NEOTECT[Text Word] OR NEOSPECT[Text Word] OR NEOTEC[Text Word]))", "generated_query": ["What is the diagnostic accuracy of tomography, emission-computed, positron-emission tomography, computed tomography, flourodeoxyglucose F18, and other imaging modalities in detecting lung neoplasms, including those of the adenocarcinoma, angiosarcoma, chrondosarcoma, and sarcoma types, in patients with pulmonary conditions such as emphysema, dysphonia, lymphoma, blastoma, microcytic, or tumors?", "What is the effectiveness of diagnostic imaging and imaging agents such as CT, ECT, PET, SPECT, and neotectomy in the treatment of lung neoplasms such as NSCLC, adenocarcinoma, angiosarcoma, chrondosarcoma, sarcoma, teratoma, lymphoma, blastoma, microcytic, and tumors?", "What is the diagnostic accuracy of imaging techniques such as tomography, emission-computed, positron-emission tomography, computed tomography, and fluorodeoxyglucose F18 in detecting lung neoplasms such as neo SCLC, adenocarcinoma, angiosarcoma, chondosarcoma, sarcoma, lymphoma, and blastoma?", "What is the diagnostic accuracy of tomography, emitted-computed, positron-emission tomography, spiral computed, and Fluorodeoxyglucose F18 in detecting lung neoplasms such as adenocarcinoma, angiosarcoma, chrondosarcoma, teratoma, lymphoma, blastoma, and microcytic tumors?", "What is the diagnostic accuracy of lung neoplasms, including NSCLC, emitting tomography, computed tomography, positron-emission tomography, and fluorodeoxyglucose F18 in detecting these lesions?", "What is the effectiveness of lung neoplasms such as NSCLC, emitted-computed tomography, positron-emission tomography, computed tomography, and fluorodeoxyglucose F18 in detecting lung cancer, carcinoma, adenocarcinoma, angiosarcoma, chrondosarcoma, teratoma, lymphoma, and blastoma?", "What is the diagnostic accuracy of lung neoplasms such as NSCLC, adenocarcinoma, and teratoma, as detected by tomography, emission-computed, positron-emission tomography, and fluorodeoxyglucose F18, in adult patients with pulmonary conditions?", "What is the effectiveness of lung neoplasms such as NSCLC, adenocarcinoma, angiosarcoma, and tomography, emitted-computed, in detecting lung cancers, carcinomas, adenocarcinoma, and angiosarcoma in patients with lung conditions such as emphysema, empyema, and mesothelioma?", "What is the diagnostic accuracy of tomography, emitted-computed, positron-emission, and other imaging modalities in detecting lung neoplasms such as NSCLC, adenocarcinoma, and angiosarcoma, as well as other types of lungs, in patients with symptoms suggestive of neoplasms?", "What is the diagnostic accuracy of lung neoplasms, including NSCLC, adenocarcinoma, angiosarcoma, chrondosarcoma, sarcoma, teratoma, lymphoma, blastoma, microcytic, and tumors, in patients undergoing tomography, emission-computed, positron-emission tomography, computed-tomography, fluorodeoxyglucose F18, and imaging studies such as PET, SPECT, and neotect?"]}
{"id": "CD009372", "boolean": "(Magnetic Resonance Angiography[mesh:noexp] OR angiography[mesh:noexp] OR cerebral angiography[mesh:noexp] OR Magnetic Resonance Imaging[mesh:noexp] OR Tomography, X-Ray Computed[mesh] AND angiography[mesh:noexp] OR cerebral angiography[mesh:noexp] OR (MRA[Text Word] AND ((magnetic resonance[Text Word] OR MR[Text Word] OR MRI[Text Word] OR NMR[Text Word]) AND (angiogra*[Text Word] OR arteriogra*[Text Word])) AND ((Compute*[Text Word] OR CT[Text Word] OR CAT[Text Word]) AND (angiogra*[Text Word] OR arteriogra*[Text Word])))) AND (\"sensitivity and specificity\"[mesh] OR diagnostic errors[mesh] OR likelihood function[mesh:noexp] OR (sensitiv*[Text Word] OR specificity[Text Word]) OR (predictive[Text Word] AND value*[Text Word]) OR ((false[Text Word] AND positive*[Text Word]) OR (false[Text Word] AND negative*[Text Word])) OR (observer[Text Word] AND variation*[Text Word]) OR (roc[Text Word] AND curve*[Text Word]) OR (likelihood[Text Word] AND ratio*[Text Word])) AND (angiography[mesh:noexp] AND (subtraction technique[mesh:noexp] OR subtraction[Text Word]) OR ((digital subtract*[Text Word] OR catheter[Text Word] OR cerebral[Text Word] OR brain[Text Word]) AND (angiogra*[Text Word] OR arteriogra*[Text Word])) OR (DSA[Text Word] OR IADSA[Text Word])) AND (basal ganglia hemorrhage[mesh] OR intracranial hemorrhages[mesh:noexp] OR cerebral hemorrhage[mesh:noexp] OR intracranial hemorrhage, hypertensive[mesh:noexp] OR cerebrovascular disorders[mesh:noexp] OR ICH[Text Word] OR ((brain*[Text Word] OR cerebr*[Text Word] OR cerebell*[Text Word] OR intracerebral[Text Word] OR intracran*[Text Word] OR parenchymal[Text Word] OR intraparenchymal[Text Word] OR intraventricular[Text Word] OR infratentorial[Text Word] OR supratentorial[Text Word] OR basal gangli*[Text Word] OR putaminal[Text Word] OR putamen[Text Word] OR posterior fossa[Text Word] OR hemispher*[Text Word] OR stroke[Text Word] OR apoplex*[Text Word]) AND (h*[Text Word] OR bleed*[Text Word])))", "generated_query": ["What is the diagnostic accuracy of magnetic resonance angiography, cerebral angiography, and imaging modalities such as computed tomography, catheterization, and brain death in patients with basal ganglia hemorrhages, intracranial hemorrhages, cerebral hemorrhages, and intraventricular death?", "What is the diagnostic accuracy of magnetic resonance angiography, cerebral angiography, and tomography, x-ray computed in detecting brain death, cerebral death, and intracranial death in patients with basal ganglia hemorrhages, intracranial hemorrhages, cerebral hemorrhage, and brain death?", "What is the effectiveness of magnetic resonance angiography, cerebral angiography, and tomography, x-ray computed, in detecting brain death, intracerebral hemorrhage, cerebral hemorrhage, ICH, and stroke in patients undergoing surgical procedures, including subtraction techniques and digital subtractive imaging, in patients with conditions such as hypertension, epilepsy, and intracranial surgery? Additionally, what is the diagnostic accuracy of magnetic resonance imaging, CT, CAT, and DSA in detecting these conditions in patients with brain death, intracerebral hemorrhage, cerebral hemorrhage, ICH, and stroke?", "What is the diagnostic accuracy of magnetic resonance angiography, cerebral angiography, MRA, CT, and CAT in detecting basal ganglia hemorrhage, intracranial hemorrhages, cerebral hemorrhage, intracranial hemorrhage, and ICH in patients with conditions such as hypertensive encephalopathy, brain death, cerebral death, and intracerebral death?", "What is the diagnostic accuracy of magnetic resonance angiography, cerebral angiography, and computed tomography in detecting basal ganglia hemorrhage, intracranial hemorrhage, and cerebral hemorrhage? Additionally, what is the diagnostic value of magnetic resonance imaging, tomography, computed, and angiography in detecting these types of hemorrhages, including those of hypertensive patients, and what are the predictive values of these tests?", "What is the diagnostic accuracy of magnetic resonance angiography, cerebral angiography, CT, CAT, MRI, and ultrasonography in detecting brain death, intracranial hemorrhage, cerebral hemorrhage, hypertensive brain death, and brain death caused by stroke, apoplexy, or hemispherectomy?", "What is the diagnostic accuracy of magnetic resonance angiography, cerebral angiography, and other imaging modalities in detecting brain death, intracranial hemorrhage, cerebral hemorrhage, and other related conditions? The query should also include sensitivity and specificity, likelihood functions, and diagnostic errors, as well as other factors such as observer variations and diagnostic tests, in order to provide the most accurate comparison of imaging modalities.", "What is the diagnostic accuracy of magnetic resonance angiography, cerebral angiography, and MRA in detecting brain death, intracranial hemorrhage, and cerebral hemorrhage, including hypertensive and infratentorial, in patients with conditions such as stroke, apoplexy, or hemispheres, using various techniques such as subtraction, digital subtract, catheter, and DSA?", "What is the effectiveness of magnetic resonance angiography, cerebral angiography, and computed tomography in detecting brain death, intracranial hemorrhages, cerebral hemorrhage, and intracerebral bleeding, including hemispheric and posterior fossa death, in patients with lesions of the basal ganglia, arteries, or brain? Additionally, what is the diagnostic accuracy of magnetic resonance imaging, computed tomography, DSA, IADSA, and other imaging modalities in detecting these conditions, including brain death, intracranial hemorrhages, cerebral hemorrhage, and intraventricular death?", "What is the effectiveness of magnetic resonance angiography, cerebral angiography, and imaging modalities such as CT, CAT, and DSA in detecting and managing cerebral hemorrhages, including those from hypertension and brain death, in patients undergoing surgical procedures?"]}
{"id": "CD010276", "boolean": "(Carcinoma, squamous cell[mesh] OR Precancerous conditions[mesh] OR (tumor*[All Fields] OR tumour*[All Fields] OR cancer*[All Fields] OR carcinoma*[All Fields] OR carcinogen*[All Fields] OR neoplas*[All Fields] OR malignan*[All Fields] OR metasta*[All Fields] OR dysplas*[All Fields] OR lesion*[All Fields] OR ulcer*[All Fields]) OR (pre-cancer*[All Fields] OR precancer*[All Fields] OR premalignan*[All Fields] OR precursor*[All Fields] OR \"lichen planus\"[All Fields] OR leukoplakia[All Fields] OR \"submucous fibrosis\"[All Fields] OR candidiasis[All Fields] OR erythroplakia[All Fields] OR erythroplas*[All Fields] OR erythroleukoplakia[All Fields] OR hyperplas*[All Fields] OR hyperkeratos*[All Fields] OR (actinic[All Fields] AND keratosis[All Fields]))) AND (Cytodiagnosis[mesh:noexp] OR Saliva[mesh:noexp] OR Luminescent Agents[mesh] OR Light[mesh:noexp] OR Acetic acid[mesh:noexp] OR Tomography, Optical Coherence[mesh:noexp] OR Diagnosis, Oral[mesh:noexp] OR Cytophotometry[mesh:noexp] OR Luminescence[mesh] OR Tolonium chloride[mesh:noexp] OR Cytological techniques[mesh:noexp] OR Tumor Markers, Biological[mesh:noexp] OR Spectrometry, fluorescence[mesh:noexp] OR Physical examination[mesh:noexp] OR Fluorescence[mesh:noexp] OR Spectrophotometry[mesh:noexp] OR Mass screening[mesh:noexp] OR Coloring agents[mesh:noexp] OR lumenoscop*[All Fields] OR acetowhite[All Fields] OR (visual*[All Fields] AND (\"light emitting diode\"[All Fields] OR \"blue spectrum\"[All Fields] OR LED[All Fields] OR luminous*[All Fields])) OR ((analy*[All Fields] OR screen*[All Fields] OR test*[All Fields] OR examin*[All Fields]) AND (blood[All Fields] OR saliva[All Fields])) OR (brush*[All Fields] AND (cytodiagnosis[All Fields] OR cytopathology[All Fields])) OR (tissue[All Fields] AND reflect*[All Fields]) OR (brush[All Fields] AND biops*[All Fields]) OR (visual*[All Fields] AND (exam*[All Fields] OR inspect*[All Fields] OR screen*[All Fields])) OR (\"modified liquid based cytology\"[All Fields] OR (exfoliat*[All Fields] AND cytolog*[All Fields])) OR (\"tolonium chloride\"[All Fields] OR \"tolu* blue\"[All Fields] OR \"tolu* b\"[All Fields] OR tblue[All Fields] OR t-blue[All Fields]) OR ((tumor*[All Fields] OR tumour*[All Fields] OR cancer*[All Fields] OR carcinoma*[All Fields] OR neoplas*[All Fields] OR carcinogen*[All Fields] OR malignan*[All Fields] OR metata*[All Fields] OR lesion*[All Fields] OR ulcer*[All Fields]) AND (fluorescen*[All Fields] OR autofluorescen*[All Fields] OR luminescen*[All Fields] OR chemiluminescen*[All Fields])) OR (acetic acid[All Fields] AND (wash*[All Fields] OR rins*[All Fields])) OR ((\"tumo* marker*\"[All Fields] OR \"neoplas* marker*\"[All Fields]) AND (blood[All Fields] OR saliva[All Fields])) OR ((oral*[All Fields] OR mouth*[All Fields]) AND (exam*[All Fields] OR histolog*[All Fields] OR check*[All Fields] OR inspect*[All Fields])) OR (visuali*[All Fields] AND adjunct*[All Fields]) OR (vizilite[All Fields] OR microlux*[All Fields] OR orascoptic[All Fields] OR velscope[All Fields]) OR (\"oral cdx\"[All Fields] OR oralcdx[All Fields]) OR (tolu*[All Fields] AND (dye*[All Fields] OR rins*[All Fields] OR stain*[All Fields] OR wash*[All Fields]))) AND (Oral candidiasis[mesh:noexp] OR Mouth neoplasms[mesh] OR Lichen Planus, Oral[mesh:noexp] OR Oral submucous fibrosis[mesh:noexp] OR (oral*[All Fields] OR mouth*[All Fields] OR bucca*[All Fields] OR \"oral cavit*\"[All Fields] OR lip[All Fields] OR lips[All Fields] OR tongue*[All Fields] OR gingiv*[All Fields] OR palat*[All Fields] OR cheek*[All Fields] OR \"intra oral*\"[All Fields] OR intraoral*[All Fields] OR gum[All Fields] OR gums[All Fields] OR labial*[All Fields] OR (oral[All Fields] AND mucosa*[All Fields]) OR (mouth[All Fields] AND mucosa*[All Fields])) AND (tumor*[All Fields] OR tumour*[All Fields] OR cancer*[All Fields] OR carcinoma*[All Fields] OR carcinogen*[All Fields] OR neoplas*[All Fields] OR malignan*[All Fields] OR metasta*[All Fields] OR dysplas*[All Fields] OR lesion*[All Fields] OR ulcer*[All Fields] OR pre-cancer*[All Fields] OR precancer*[All Fields] OR premalignan*[All Fields] OR precursor*[All Fields] OR \"lichen planus\"[All Fields] OR leukoplakia[All Fields] OR \"submucous fibrosis\"[All Fields] OR candidiasis[All Fields] OR erythroplakia[All Fields] OR erythroplas*[All Fields] OR erythroleukoplakia[All Fields] OR hyperplas*[All Fields] OR hyperkerato*[All Fields] OR (actinic[All Fields] AND keratosis[All Fields])))", "generated_query": ["What is the diagnostic accuracy of various screening tests and imaging modalities in detecting oral carcinoma, dysplasia, lesions, ulcers, and metastasis, including those of the lichen planus, leukoplakia, and submucous fibrosis, in patients with clinical features suggestive of these conditions, using the most effective screening tests and imaging modalities, such as those that utilize acetic acid, toluene, and light?", "What is the diagnostic accuracy of cytodiagnosis, saliva, and luminous agents in detecting oral candidiasis, neoplasms, and malignancies such as tumors, ulcers, pre-cancers, and metastasis?", "What is the diagnostic accuracy of cytodiagnosis, Saliva, Luminescent Agents, Light, Acetic acid, Tomography, Optical Coherence, Diagnosis, Oral, Cytophotometry, Luminescence, Analyze, Test, Examine, Check, Inspect, oral cavities, gums, oral mucosa, and saliva in detecting oral neoplasms such as lichen planus, lesions, ulcers, oral cavities, and gums, and biological markers such as tumors, metastasis, and dysplasia?", "What is the effectiveness of screening and diagnostic tests, including Cytodiagnosis, Saliva, Luminescent Agents, Light, Acetic acid, Tomography, Optical Coherence, Diagnosis, Oral, Cytophotometry, Luminescence, Tolonium chloride, Cytological techniques, Tumor Markers, Biological, Spectrometry, fluorescence, Physical examination, Fluorescence, Analysis, screen, test, oral examination, and biopsy, for detecting oral candidiasis, Mouth neoplasms, lichen planus, leukoplakia, ulcer, prem-cancer, and pre-cancer in patients with symptoms suggestive of oral cavities, mucositis, oral wounds, lesions, ulcers, ultrasonography, CT, MRI, oral surgery, biopsy, or intraoral examination?", "What is the effectiveness of screening methods, including acetic acid, saliva, luminescent agents, light, and coloring agents, for detecting oral cdx, mouth neoplasms, lichen planus, leukoplakia, and submucous fibrosis?", "What is the diagnostic accuracy of cytodiagnosis, saliva, luminescent agents, light, acetic acid, and tomography, optical coherence, in detecting oral cancer, lichen planus, leukoplakia, pre-cancer, and metastaemia?", "What is the diagnostic accuracy of cytodiagnosis, saliva, luminescent agents, light, acetic acid, toluene chloride, cytographic techniques, Tumor Markers, Biological, Spectrometry, fluorescence, and imaging modalities such as oral cdx, tomography, optical coherence, diagnostic ultrasonography, and coloring agents in detecting oral candidiasis, lichen planus, leukoplakia, dysplasia, lesions, ulcers, and pre-cancerous conditions?", "What is the effectiveness of screening and diagnostic tests for detecting carcinoma, including squamous cell, precancerous conditions, and metastasis, as well as tumors, ulcers, ulcus, lesions, ulcus, and ulcus, using fluorescence, light, and acetowhite?", "What is the effectiveness of screening methods, diagnostic tests, and imaging techniques in detecting oral cancer, lichen planus, leukoplakia, ulcers, pre-cancer, and metastasis in patients with symptoms suggestive of these conditions, including but not limited to dysplasia, lesions, ulcers, pre-cancer, and metastasis, as compared to placebo or other treatments, in terms of sensitivity, specificity, likelihood ratios, and area under the ROC curve?", "What is the effectiveness of screening methods, diagnostic tests, and imaging modalities in detecting oral cavities, neoplasms, lichen planus, oral submucous fibrosis, and other related conditions?"]}
{"id": "CD009551", "boolean": "(Aspergillosis[mesh] OR Pulmonary Aspergillosis[mesh] OR Aspergillus[mesh] OR aspergillosis[Title/Abstract] OR aspergillus[Title/Abstract] OR aspergilloma[Title/Abstract] OR \"A.fumigatus\"[Title/Abstract] OR \"A. flavus\"[Title/Abstract] OR \"A. clavatus\"[Title/Abstract] OR \"A. terreus\"[Title/Abstract] OR \"A. niger\"[Title/Abstract]) AND (Nucleic Acid Amplification Techniques[mesh] OR pcr[Title/Abstract] OR \"polymerase chain reaction*\"[Title/Abstract])", "generated_query": ["What is the effectiveness of nucleic acid amplification techniques, including pcr and polymerase chain reaction, in detecting aspergillosis, including A.fumigatus, A. flavus, A. clavatus, A. terreus, and A. niger?", "What is the effectiveness of nucleic acid amplification techniques, including polymerase chain reaction (PCR), in detecting Aspergillus or fungal infections, such as A.fumigatus, A. flavus, A. clavatus, A. terreus, A. niger, and other pathogenic species?", "What is the diagnostic accuracy of nucleic acid amplification techniques, including polymerase chain reaction, in detecting Aspergillosis, pulmonary, in adult patients?", "What is the effectiveness of nucleic acid amplification techniques such as pcr and polymerase chain reaction in detecting aspergillosis, pulmonary aspergillosis, A. fumigatus, A. flavus, A. clavatus, A. terreus, A. niger, and other related terms in patients with symptoms suggestive of lung disease?", "What is the diagnostic accuracy of nucleic acid amplification techniques, including polymerase chain reaction (PCR) and real-time PCR, in detecting Aspergillosis, including pulmonary Aspergillosis, in patients with symptoms suggestive of lung disease, such as coughing, shortness of breath, and chest pain?", "What is the diagnostic accuracy of nucleic acid amplification techniques, including PCR and polymerase chain reaction, in detecting Aspergillosis, pulmonary, and specifically A. fumigatus, A. flavus, A. clavatus, A. terreus, and A. niger?", "What is the diagnostic accuracy of nucleic acid amplification techniques, such as pcr and polymerase chain reaction, in detecting Aspergillosis, including A. fumigatus, A. flavus, A. clavatus, A. terreus, A. niger, and other related terms?", "What is the diagnostic accuracy of nucleic acid amplification techniques, such as PCR and polymerase chain reaction, in detecting Aspergillosis, including pulmonary Aspergillosis, in patients with symptoms suggestive of fungal infections, such as coughing, sore throat, headache, nausea, vomiting, or fever?", "What is the diagnostic accuracy of Aspergillus detection using nucleic acid amplification techniques, including pcr and polymerase chain reaction, as compared to other tests, such as culture, microscopic examination, and immunological tests?", "What is the effectiveness of nucleic acid amplification techniques such as pcr and polymerase chain reaction in detecting Aspergillosis, including pulmonary and nasal Aspergillus, and the A.fumigatus and A. flavus bacteria?"]}
{"id": "CD012019", "boolean": "(Luteinizing Hormone[mesh] OR Progesterone[mesh] OR matrix metalloproteinase 1[mesh] OR matrix metalloproteinase 2[mesh] OR matrix metalloproteinase 3[mesh] OR matrix metalloproteinase 9[mesh] OR \"tissue inhibitor of metalloproteinase-1\"[mesh] OR \"tissue inhibitor of metalloproteinase-2\"[mesh] OR Glycoproteins[mesh] OR Follistatin[mesh] OR intercellular adhesion molecule-1[mesh] OR selectins[mesh] OR t-lymphocytes[mesh] OR natural killer t-cells[mesh] OR Antibodies, Antiphospholipid[mesh] OR hla antigens[mesh] OR hla-a1 antigen[mesh] OR hla-a2 antigen[mesh] OR Integrins[mesh] OR Cysteine-Rich Protein 61[mesh] OR Vascular Endothelial Growth Factor A[mesh:noexp] OR Vitamin D-Binding Protein[mesh:noexp] OR Cytokines[mesh] OR interleukins[mesh] OR interleukin-1[mesh] OR interleukin-6[mesh] OR interleukin-8[mesh] OR interleukin-12[mesh] OR interleukin-13[mesh] OR Epidermal Growth Factor[mesh] OR Fibroblast Growth Factors[mesh] OR Platelet-Derived Growth Factor[mesh:noexp] OR Keratin-19[mesh:noexp] OR Clinical Laboratory Techniques[mesh] OR Cadherin*[Text Word] OR urinary peptide*[Text Word] OR serum placental protein*[Text Word] OR Fas ligand*[Text Word] OR estrogen receptor*[Text Word] OR MMP*[Text Word] OR Soluble adhesion molecule*[Text Word] OR neural marker*[Text Word] OR cell adhesion molecule*[Text Word] OR soluble intercellular adhesion[Text Word] OR leptin*[Text Word] OR interleukin*[Text Word] OR Total complement level*[Text Word] OR urinary marker*[Text Word] OR serum marker*[Text Word] OR inflammatory marker*[Text Word] OR cyr61[Text Word] OR Follistatin*[Text Word] OR Laboratory Test*[Text Word] OR cytokine*[Text Word] OR Anti-LDL[Text Word] OR proteomic*[Text Word] OR cysteine-rich heparin-binding protein*[Text Word] OR cell surface marker*[Text Word] OR genomic*[Text Word] OR Anti-laminin-1[Text Word] OR Selectin*[Text Word] OR TIMP*[Text Word] OR Anti-Thomsen Friedenreich antigen*[Text Word] OR microRNA*[Text Word] OR Immune cells alteration*[Text Word] OR Anti-transferrin[Text Word] OR CAMs[Text Word] OR sICAM[Text Word] OR scatter factor*[Text Word] OR Osteopontin*[Text Word] OR Antiphospholipid*[Text Word] OR progesterone receptor*[Text Word] OR MTMMP*[Text Word] OR Anti-thyroid[Text Word] OR cytokeratin-19[Text Word] OR Proteolytic enzyme*[Text Word] OR Aromatase P450[Text Word] OR microarray*[Text Word] OR VDBP-Cr[Text Word] OR hepatocyte growth factor[Text Word] OR matrix metalloproteinase*[Text Word] OR urinary VDBP corrected for creatinine expression[Text Word] OR Autoantibodies[Text Word] OR Integrin*[Text Word] OR growth factor*[Text Word] OR sVCAM*[Text Word] OR Anti-endometrial[Text Word] OR Endometrial marker*[Text Word] OR (PP 14[Text Word] OR PP14[Text Word]) OR (Anti-2HSG[Text Word] OR Heremans-Schmidt glycoprotein[Text Word]) OR (biomarker*[Text Word] OR marker*[Text Word]) OR (T helper*[Text Word] OR T supressor*[Text Word] OR T helper*[Text Word]) OR (VDBP[Text Word] OR vitamin D-binding protein*[Text Word]) OR (TGF-b[Text Word] OR transforming growth factor beta[Text Word] OR TGFb[Text Word]) OR (endometri*[Text Word] AND biops*[Text Word]) OR (MCP-I[Text Word] OR monocyte chemoattractant protein-I[Text Word]) OR (VEGF[Text Word] OR vascular endothelial growth factor*[Text Word]) OR (Ca-19-9[Text Word] OR Ca19-9[Text Word] OR cancer antigen 19-9[Text Word]) OR (HLA[Text Word] OR human leucocyte antigen*[Text Word]) OR (EGF[Text Word] OR epidermal growth factor*[Text Word]) OR (Ca-125[Text Word] OR Ca125[Text Word] OR cancer antigen 125[Text Word]) OR (FGF[Text Word] OR fibroblast growth factor*[Text Word]) OR (IGF-I[Text Word] OR insulin-like growth factor*[Text Word] OR IGF1[Text Word]) OR (sEselectin[Text Word] OR soluble E-selectin[Text Word]) OR (ANXA 1[Text Word] OR ANXA1[Text Word]) OR (TNF-a[Text Word] OR tumour necrosis factor*[Text Word]) OR (PDGF[Text Word] OR platelet derived growth factor*[Text Word]) OR (Annexin 1[Text Word] OR Annexin1[Text Word]) OR (EGFR[Text Word] OR epidermal growth factor receptor*[Text Word]) OR (TGF-a[Text Word] OR transforming growth factor alfa[Text Word] OR TGFa[Text Word]) OR (sEcadherin[Text Word] OR soluble E-cadherin[Text Word]) OR (PGP 9*[Text Word] OR PGP9*[Text Word] OR protein gene product*[Text Word]) OR (Luteinizing Hormone*[Text Word] OR LH[Text Word]) OR (MIF[Text Word] OR migration inhibitory factor*[Text Word])) AND (Endometriosis[mesh] OR Endometrio*[Text Word])", "generated_query": ["What is the effectiveness of various biomarkers, including Luteinizing Hormone, Progesterone, and matrix metalloproteinase 1, in detecting endometriosis? Additionally, what is the effectiveness of clinical laboratory tests, such as urinary VDBP, EGF, and Ca-19-9, in detecting endometriosis? Finally, what is the effectiveness of immune cells alterations, including anti-thyroid and microRNA, in detecting endometriosis?", "What is the effectiveness of laboratory tests, including those that detect endometriosis, leptinemia, urinary VDBP, and other markers, in identifying patients with a disease condition of endometriosis, fibromyoma, and urinary VDBP, and how do immune cells and cytokines contribute to the diagnosis and treatment of these conditions?", "What is the effectiveness of diagnostic tests, such as immunology and ultrasound, in detecting endometriosis, including those that measure the levels of biomarkers such as matrix metalloproteinase 9 and tissue inhibitors of metalloproteinase-1, as well as those that detect the presence of endometrial tissue or tumors, in patients with symptoms suggestive of endometriosis?", "What is the effectiveness of luteinizing hormone, progesterone, matrix metalloproteinase 1, matrix metalloproteinase 2, and other biomarkers in detecting endometriosis and identifying the stages of endometriosis? Additionally, what is the effectiveness of immunologic tests, such as CAMs, sICAM, and scatter factor, in detecting endometriosis, and what is the effectiveness of microarray and VDBP-corrected-for-creatinine tests in detecting endometriosis and identifying biomarkers?", "What is the diagnostic accuracy of various markers, including Luteinizing Hormone, Progesterone, Matrix Metalloproteinase 1, and tissue inhibitors of metalloproteinase, in detecting endometriosis? Additionally, what is the effectiveness of immune cells alteration, including T-helper and antibodin levels, in detecting endometriosis, and how do biomarkers such as VEGF and tissue healing markers such as PP 14, HLA, and EGF relate to endometriosis?", "What is the diagnostic accuracy of laboratory tests, imaging studies, and molecular markers in detecting endometriosis, including Luteinizing Hormone, Progesterone, matrix metalloproteinase 1, and tissue inhibitors of metalloproteinase 1, as markers of malignancy, as compared to normal tissues, in patients with symptoms suggestive of endometriosis?", "What is the effectiveness of using Luteinizing Hormone, Progesterone, matrix metalloproteinase 1, 2, and 3, tissue inhibitor of metalloproteinase-1, Glycoproteins, Follistatin, intercellular adhesion molecules, and other biomarkers in detecting endometriosis and other related conditions?", "What is the effectiveness of laboratory tests, imaging studies, and biomarkers in detecting endometriosis, including laparoscopic surgical procedures, ultrasonography, CT, MRI, and laboratory tests such as PP 14, anti-2HSG, HLA, and VDBP, in patients with symptoms suggestive of endometriosis?", "What is the effectiveness of luteinizing hormone, progesterone, and matrix metalloproteinase inhibitors in treating endometriosis? Additionally, what is the efficacy of immune system markers such as EGF, FGF, and TGF-a in detecting endometriosis, and what are the diagnostic tests, such as urinary VDBP, PP14, and anti-2HSG, for detecting endometriosis? Finally, what are the biomarkers, such as HLA, and endometrial markers, such as PDGF, that are useful for detecting endometriosis?", "What is the effectiveness of screening methods for detecting endometriosis, including ultrasonography, MRI, CT, and biopsy, in combination with markers such as Luteinizing Hormone, progesterone, and matrix metalloproteinase 1, 2, and 9, as well as tissue inhibitors of metalloproteinase-1, 2, and 9, and immunological markers such as anti-2HSG, HLA, and EGF?"]}
{"id": "CD008081", "boolean": "(tomography[mesh:noexp] tomography, optical coherence[mesh:noexp] OR ophthalmoscopy[mesh:noexp] OR OCT[Text Word] OR (optical*[Text Word] AND coherence*[Text Word] AND tomograph*[Text Word])) AND (diabetes mellitus[mesh] OR diabetic retinopathy[mesh:noexp] OR diabetes complications[mesh:noexp] OR diabet*[Text Word] OR retinopath*[Text Word]) AND (macular edema[mesh] OR maculopath*[Text Word] OR (CME[Text Word] OR CSME[Text Word] OR CMO[Text Word] OR CSMO[Text Word]) OR (DMO[Text Word] OR DME[Text Word]) OR (macula*[Text Word] AND oedema[Text Word]) OR (macula*[Text Word] AND edema[Text Word]))", "generated_query": ["What is the effectiveness of tomography, optical coherence, ophthalmoscopy, CT, and laser surgery in treating diabetic retinopathy, macula edema, CME, and laser surgery in patients with diabetes mellitus?", "What is the effectiveness of diagnostic imaging and visual tests such as tomography, optical coherence, ophthalmoscopy, and ultrasound in detecting diabetes mellitus, diabetic retinopathy, diabetes complications, and diabetes-induced macula edema in patients with conditions such as cataract surgery, glaucoma surgery, and strabismus surgery?", "What is the diagnostic accuracy of imaging modalities such as tomography, optical coherence, ophthalmoscopy, and ultrasound in detecting diabetes mellitus, retinopathy, and macula edema in patients with diabetes complications, including nephropathy, neurotic disorders, and diabetes?", "What is the effectiveness of tomography, optical coherence, ophthalmoscopy, and other imaging modalities in detecting diabetes mellitus, retinopathy, and diabetic complications, such as macular edema, CME, and DMO?", "What is the effectiveness of tomography, optical coherence, ophthalmoscopy, CT, and other imaging modalities in detecting diabetes mellitus, diabetic retinopathy, diabetes complications, and other eye conditions such as macula edema and macula oedema in patients with conditions such as glaucoma, cataracts, retinal ulcers, or ultrasonic surgery?", "What is the diagnostic accuracy of tomography, optical coherence, ophthalmoscopy, CT, and laser-induced fluorescence in detecting diabetes mellitus, diabetic retinopathy, and diabetes complications such as macular edema, maculopathy, CME, CSME, CMO, and DMO?", "What is the effectiveness of diagnostic imaging techniques such as tomography, optical coherence, ophthalmoscopy, CT, and ultrasound in detecting diabetes mellitus, diabetic retinopathy, and diabetes complications such as macular edema, maculopathy, CME, CSME, CMO, and DMO?", "What is the diagnostic accuracy of tomography, optical coherence, ophthalmoscopy, OCT, and other imaging modalities in detecting diabetes mellitus, diabetic retinopathy, diabetes complications, and macular edema?", "What is the diagnostic accuracy of imaging modalities such as tomography, optical coherence, ophthalmoscopy, and OCT in detecting diabetes mellitus, diabetic retinopathy, diabet*, retinopathy, and macular edema in patients with CME, CSME, CMO, and DMO conditions?", "What is the effectiveness of tomography, optical coherence, ophthalmoscopy, CT, and other imaging modalities in detecting diabetes mellitus, diabetic retinopathy, and diabetes complications such as macula edema or CME?"]}
{"id": "CD009185", "boolean": "(c-Reactive Protein[mesh:noexp] OR c-reactive protein[Text Word] OR CRP[Text Word]) AND (Pyelonephritis[mesh:noexp] OR Urinary Tract Infections[mesh:noexp] OR urinary tract infection*[Text Word] OR pyelonephritis[Text Word] OR (UTI[Text Word] OR UTIs[Text Word])) AND (Kidney[mesh:noexp] OR Technetium Tc 99m Dimercaptosuccinic Acid[mesh:noexp] OR Radionuclide Imaging[mesh:noexp] OR Succimer[mesh:noexp] OR DMSA[Text Word] OR dimercaptosuccin*[Text Word] OR scintigra*[Text Word]) AND (Blood Sedimentation[mesh:noexp] OR ESR[Text Word] OR blood sedimentation[Text Word] OR erythrocyte sedimentation rate[Text Word])", "generated_query": ["What is the diagnostic accuracy of c-reactive protein, Pyelonephritis, urinary tract infections, and DMSA in detecting blood and urine sedimentation rates, as measured by ESR and plasma, in patients with conditions related to the urinary tract, kidney, and technetium Tc 99m Dimercaptosuccinic acid?", "What is the effectiveness of c-reactive protein, pyelonephritis, urinary tract infections, and imaging techniques such as DMSA, succimer, and scintigraphy in detecting blood clots and detecting the development or progression of blood clots in patients with conditions such as kidney disease or urinary tract infections?", "What is the effectiveness of c-reactive protein, Pyelonephritis, urinary tract infections, and DMSA in detecting kidney disease, including nephritis, urinary tract infections, and pyelonephritis, in patients with blood sedimentation, ESR, and blood cell counts?", "What is the effectiveness of c-reactive protein, Pyelonephritis, urinary tract infections, and other imaging modalities in detecting nephritis and urinary tract infections in patients with abnormal blood sedimentation rates or ESR?", "What is the effectiveness of using c-reactive protein, Pyelonephritis, Urinary Tract Infections, and ultrasound imaging in detecting and diagnosing kidney problems such as nephritis, pyelonephritis, urinary tract infections, and ultrasound imaging in patients with conditions such as type 1 diabetes, hypertension, and chronic kidney disease?", "What is the effectiveness of using c-reactive protein, pyelonephritis, urinary tract infections, urinary tract infection, and scintigraphy in detecting and imaging kidney damage?", "What is the effectiveness of c-reactive protein, Pyelonephritis, urinary tract infections, and other imaging and diagnostic tests in detecting kidney disease, including those caused by diabetes, hypertension, and obesity?", "What is the effectiveness of using c-reactive protein, Pyelonephritis, urinary tract infections, and scintigraphy in detecting kidney infections?", "What is the effectiveness of c-reactive protein, pyelonephritis, urinary tract infections, and DMSA in detecting nephritic disease in patients with conditions such as kidney disease, technetium Tc 99m, and succimer, in patients with conditions such as kidney disease, technetium Tc 99m, and succimer, using blood sedimentation, ESR, and blood pressure?", "What is the effectiveness of c-reactive protein, pyelonephritis, urinary tract infections, and urinary tract infections in detecting and monitoring these conditions in patients with kidney or urinary infections, as compared to other diagnostic tests such as DMSA, scintigraphy, and erythrocyte sedimentation rate?"]}
{"id": "CD010339", "boolean": "(\"Choledocholithiasis\"[mesh] OR \"Common Bile Duct Calculi\"[mesh] OR \"Cholelithiasis\"[mesh] OR choledocholithiasis[Title/Abstract] OR cholelithiasis[Title/Abstract]) AND (\"Tomography, X-Ray Computed\"[mesh] OR \"Cholangiopancreatography, Magnetic Resonance\"[mesh] OR \"Liver Function Tests\"[mesh] OR \"Magnetic Resonance Imaging\"[mesh] OR \"Ultrasonography\"[mesh] OR \"Endosonography\"[mesh] OR \"Cholangiography\"[mesh] OR CT[Title/Abstract] OR tomodensitometry[Title/Abstract] OR MRI[Title/Abstract] OR NMRI[Title/Abstract] OR zeugmatogra*[Title/Abstract] OR echogra*[Title/Abstract] OR ultrason*[Title/Abstract] OR ultrasound[Title/Abstract] OR EUS[Title/Abstract] OR cholangiogra*[Title/Abstract] OR cholangio*[Title/Abstract] OR cholangiosco*[Title/Abstract] OR choledochosco*[Title/Abstract] OR ERCP[Title/Abstract] OR MRCP[Title/Abstract] OR liver function test[Title/Abstract] OR liver function tests[Title/Abstract] OR ((computed[Title/Abstract] OR computerised[Title/Abstract] OR computerized[Title/Abstract] OR magneti*[Title/Abstract] OR MR[Title/Abstract] OR NMR[Title/Abstract] OR proton[Title/Abstract]) AND (tomogra*[Title/Abstract] OR scan[Title/Abstract] OR scans[Title/Abstract] OR imaging[Title/Abstract] OR cholangiogra*[Title/Abstract])))", "generated_query": ["What is the diagnostic imaging and liver function tests most effective for detecting choledocholithiasis, cholelithiasis, and duodenal calculi? Specifically, I am interested in studies that utilize tomography, x-ray computed, cholangiopancreatography, magnetic resonance, liver function tests, MRCP, and NMR in detecting choledocholithiasis and duodenal calculi.", "What is the diagnostic accuracy of imaging and liver function tests in detecting choledocholithiasis, cholelithiasis, and duct calculi? Additionally, what is the accuracy of tomography, x-ray computed, cholangiopancreatography, liver function tests, magnetic resonance, ultrasonography, endosonography, cholangioscopy, choledochoscopy, ERCP, MRCP, and liver function tests in detecting these conditions?", "What is the diagnostic accuracy of choledocholithiasis, cholelithiasis, and bile duct calculi, as detected by tomography, x-ray computed, cholangiopancreatography, magnetic resonance, liver function tests, and ultrasonography, in patients with symptoms suggestive of gallbladder disease?", "What are the most effective diagnostic imaging and liver function tests for detecting choledocholithiasis, cholelithiasis, and liver disease, including tomography, x-ray computed, cholangiopancreatography, magnetic resonance, liver function tests, and ultrasonography? Additionally, what is the diagnostic accuracy of endosonography, cholangiography, CT, and ultrasonography in detecting choledocholithiasis, cholelithiasis, and liver disease? Finally, what is the diagnostic accuracy of ultrasonography, endosonography, cholangiography, CT, and ultrasonography in detecting choledocholithiasis, cholelithiasis, and liver disease, including computed tomography, cholangiopancreatography, magnetic resonance, and liver function tests?", "What are the most effective diagnostic imaging and liver function tests for detecting choledocholithiasis, common bile duct calculi, and cholelithiasis? This includes tomography, x-ray computed, cholangiopancreatography, magnetic resonance, echolithography, ultrasonography, endosonography, cholangiography, CT, and tomodensity in patients with symptoms suggestive of choledocholithiasis, common bile duct calculi, or cholelithiasis? Additionally, what are the most effective diagnostic imaging and liver function tests for detecting choledocholithiasis, common bile duct calculi, or cholelithiasis in patients with symptoms suggestive of choledocholithiasis, common bile duct calculi, or cholelithiasis, and what are the most effective imaging and liver function tests for detecting choledocholithiasis, common bile duct calculi, or cholelithiasis in patients with symptoms suggestive of choledocholithiasis, common b", "What is the diagnostic accuracy of ultrasonography, endosonography, cholangiopancreatography, liver function tests, and magnetic resonance imaging in detecting choledocholithiasis, common bile duct calculi, cholelithiasis, and other pancreatic conditions?", "What is the diagnostic accuracy of tomography, x-ray computed, cholangiopancreatography, magnetic resonance, liver function tests, and ultrasonography in detecting choledocholithiasis, bile duct calculi, and liver disease?", "What is the diagnostic accuracy of imaging and liver function tests, including tomography, x-ray computed, cholangiopancreatography, and liver biopsy, in detecting choledocholithiasis, cholelithiasis, and common bile duct calculi?", "What are the most effective diagnostic imaging and liver function tests for detecting choledocholithiasis, common bile duct calculi, and cholelithiasis? This includes studies on the use of CT, tomography, x-ray computed, cholangiopancreatography, magnetic resonance, echogra*, ultrasonography, endosonography, cholangiography, CT, and liver function tests in patients with symptoms suggestive of choledocholithiasis, common bile duct calculi, or cholelithiasis?", "What is the diagnostic imaging and liver function tests that are effective for detecting choledocholithiasis, common bile duct calculi, and cholelithiasis? This includes studies on the use of tomography, x-ray computed, cholangiopancreatography, magnetic resonance, liver function tests, and imaging techniques such as ultrasonography, endosonography, cholangioscopy, and ERCP?"]}
{"id": "CD010653", "boolean": "(Diagnosis[mesh:noexp] OR \"International Classification of Diseases\"[mesh] OR \"Sensitivity and Specificity\"[mesh:noexp] OR \"Diagnostic and Statistical Manual of Mental Disorders[mesh] OR \"Research Diagnostic Criteria\"[All Fields] OR \"present state examination\"[All Fields] OR PSE[All Fields] OR RDC[All Fields] OR bleuler[All Fields] OR \"international pilot study of schizophrenia\"[All Fields] OR IPSS[All Fields] OR \"new haven schizophrenia index\"[All Fields] OR NHSI[All Fields] OR \"operational criteria\"[All Fields] OR ICD[All Fields] OR schneider[All Fields] OR kraepelin[All Fields] OR Feighner[All Fields] OR DSM[All Fields] OR (operation*[All Fields] AND criteri*[All Fields])) AND (Schizophrenia[mesh] OR schizophren*[All Fields])", "generated_query": ["What is the diagnostic accuracy of the International Classification of Diseases, the Sensitivity and Specificity of diagnostic tests, the diagnostic and statistical manual of mental disorders, and other screening instruments in identifying schizophrenia and related disorders in patients with present state examinations, PSE, RDC, and bleuler syndrome?", "What are the diagnostic tests and criteria for identifying schizophrenia, as well as the specificity and sensitivity of these tests, in studies that include the International Classification of Diseases, the Sensitivity and Specificity of the tests, the Diagnostic and Statistical Manual of Mental Disorders, the Research Diagnostic Criteria, the present state examination, and the PSE? Additionally, what are the operational criteria, ICD, and schneider-kraepelin tests for identifying schizophrenia, and what is the effectiveness of these tests in studies that investigate the diagnosis and treatment of schizophrenia?", "What are the diagnostic tests or screening tools most effective for identifying individuals with schizophrenia, including the International Classification of Diseases, sensitivity and specificity, diagnostic and statistical manual of mental disorders, research diagnostic criteria, and the new haven schizophrenia index, as compared to other screening tools such as the Mental Health Screening Questionnaire and the Present State Examination? Additionally, what are the most effective operational criteria, such as the ICD and DSM, for diagnosing schizophrenia and related disorders, including paranoid schizophrenia and manic-depressive disorder, and what are the most effective screening tests or diagnostic tests for identifying individuals with these conditions? Finally, what are the most effective diagnostic tests or screening tools for identifying individuals with these conditions, including the new haven schizophrenia index, and what are the most effective operational criteria, such as the ICD and DSM, for diagnosing these conditions?", "What are the most effective diagnostic tests or informal screening questions for identifying patients with schizophrenia, including the International Classification of Diseases, the Sensitivity and Specificity of diagnostic tests, the Diagnostic and Statistical Manual of Mental Disorders, the Research Diagnostic Criteria, and the present state examination? Additionally, what are the operational criteria and diagnostic tests that are used in screening and diagnosing patients with schizophrenia, including the ICD, Feighner, and DSM, as well as other informal screening questions, such as those in the New Haven Schizophrenia Index? Finally, what is the effectiveness of these diagnostic tests and informal screening questions in identifying patients with schizophrenia and other related disorders?", "What is the diagnostic accuracy of the International Classification of Diseases, 9th Edition, and other diagnostic criteria in identifying individuals with schizophrenia, including those with multiple symptoms, those who are at risk of developing schizophrenia, and those who have a mild form of schizophrenia?", "What are the diagnostic tests, including the International Classification of Diseases, the DSM, and the RDC, that are effective for identifying schizophrenia in patients with symptoms such as hallucinations, delusions, and other perceptual disturbances? Additionally, what are the most sensitive and specific diagnostic tests, such as the NHSI, the operational criteria, and the ICD, for identifying patients with schizophrenia?", "What is the diagnostic accuracy of the International Classification of Diseases, 10th revision (ICD-10), Sensitivity and Specificity, Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5), Research Diagnostic Criteria, and present state examination in identifying patients with schizophrenia or who are in a psychiatric crisis?", "What is the diagnostic accuracy of the International Classification of Diseases, 10th Revision, Clinical Modification (ICD-10-CM), Sensitivity and Specificity, Diagnostic and Statistical Manual of Mental Disorders, Research Diagnostic Criteria, Bleuler, International pilot study of schizophrenia, IPSS, NHSI, and operational criteria in identifying patients with schizophrenia?", "What is the diagnostic accuracy of the International Classification of Diseases, the Sensitivity and Specificity, the Diagnostic and Statistical Manual of Mental Disorders, the Research Diagnostic Criteria, the bleuler, the internationa pilot study of schizophrenia, the IPSS, the new haven schizophrenia index, and the operational criteria in detecting schizophrenia?", "What are the most effective diagnostic tests for identifying schizophrenia, including the ICD, DSM, and various diagnostic criteria? Additionally, what are the most effective screening tests for identifying patients at risk for schizophrenia, such as the NHSI, IPSS, and new haven schizophrenia index? Finally, what are the most effective operational criteria for diagnosing and managing schizophrenia, including the bleuler, international pilot study of schizophrenia, and DSM?"]}
{"id": "CD010542", "boolean": "(Elasticity Imaging Techniques[mesh] OR transient elastograph*[All Fields] OR fibroscan[All Fields]) AND (liver biops*[All Fields] OR Biopsy, Needle[mesh]) AND (liver cirrhosis[mesh] OR (hepatic[All Fields] OR liver[All Fields]) AND (fibrosis[All Fields] OR cirrhosis[All Fields]))", "generated_query": ["What is the effectiveness of elasticity imaging techniques, such as elastography and fibroscan, in detecting liver biopsies, needle biopsies, and hepatic conditions such as fibrosis and cirrhosis in patients with conditions related to inflammation, metabolic disorders, or hepatic conditions?", "What is the effectiveness of Elasticity Imaging Techniques such as elastography, fibroscan, and liver biopsy in detecting liver conditions such as hepatic, liver, and fibrosis, as well as cirrhosis, in patients with symptoms suggestive of liver disease?", "What is the effectiveness of elasticity imaging techniques such as elastography, fibroscans, and liver biopsy in detecting liver conditions such as hepatic and liver, as well as identifying markers such as fibrosis and cirrhosis?", "What is the effectiveness of Elasticity Imaging Techniques, such as elastography and fibroscanner, in the diagnosis and management of liver biopsies, including those with hepatic and liver conditions, as well as any conditions involving fibrosis or cirrhosis?", "What is the effectiveness of elasticity imaging techniques, including elastography, fibroscan, and liver biopsy, in detecting liver conditions such as hepatic and liver disease, as well as fibrosis and cirrhosis, in patients with symptoms suggestive of liver conditions?", "What is the effectiveness of elasticity imaging techniques, such as elastography and fibroscan, in the diagnosis and management of liver biopsies, including those with hepatic and liver conditions, as well as conditions such as fibrosis and cirrhosis?", "What is the effectiveness of elasticity imaging techniques, including elastography, fibroscan, and transient elastometry, in the diagnosis and management of liver biopsies, Needle, and fibrosis, as well as detecting liver conditions such as hepatic or liver disease, in patients with symptoms suggestive of hepatic or liver conditions, such as fatigue, dizziness, stomach aches, and abdominal pain?", "What is the effectiveness of elasticity imaging techniques, including elastography, fibroscans, and liver biopsies, in detecting liver conditions such as fibrosis and cirrhosis in patients with hepatic or liver conditions?", "What is the diagnostic accuracy of elasticity imaging techniques, such as elastography and fibroscan, in detecting liver biopsies, such as those with hepatic or liver conditions, as well as detecting liver cirrhosis or fibrosis, using various elastometric and fibrometric measurements?", "What is the effectiveness of elasticity imaging techniques, including elastography, fibroscan, and biopsy, in detecting liver biopsy or fibrosis in patients with conditions such as hepatic or liver disease, and how do they compare to traditional liver tests such as ALT or AST?"]}
{"id": "CD010896", "boolean": "(Tomography, Emission-Computed[mesh:noexp] OR Tomography, Emission-Computed, Single-Photon[mesh:noexp] OR SPECT[Title/Abstract] OR SPET[Title/Abstract] OR single photon emission tomography[Title/Abstract] OR single photon emission computed tomography[Title/Abstract] OR \"SPECT/CT\"[Title/Abstract]) AND (Delirium, Dementia, Amnestic, Cognitive Disorders[mesh:noexp] OR Dementia[mesh] OR Frontotemporal Lobar Degeneration[mesh:noexp] OR Primary Progressive Nonfluent Aphasia[mesh:noexp] OR Delirium[mesh:noexp] OR Aphasia, Primary Progressive[mesh:noexp] OR dement*[Title/Abstract] OR \"benign senescent forgetfulness\"[Title/Abstract] OR alzheimer*[Title/Abstract] OR \"primary progressive aphasia\"[Title/Abstract] OR \"Frontotemporal lobar degeneration\"[Title/Abstract] OR \"progressive non-fluent aphasia\"[Title/Abstract] OR (chronic[Title/Abstract] AND cerebrovascular[Title/Abstract]) OR (\"organic brain disease\"[Title/Abstract] OR \"organic brain syndrome\"[Title/Abstract]) OR (cerebr*[Title/Abstract] AND deteriorat*[Title/Abstract]) OR (cerebral*[Title/Abstract] AND insufficient*[Title/Abstract]) OR (pick*[Title/Abstract] AND disease[Title/Abstract]) OR (lewy*[Title/Abstract] AND bod*[Title/Abstract]) OR (FTD[Title/Abstract] OR FTLD[Title/Abstract]))", "generated_query": ["What is the effectiveness of diagnostic imaging and computed tomography in identifying Alzheimer's disease, dementia, amnestic, cognitive disorders, and other related conditions in patients with complaints of delirium, dimentia, amnestic, cognitive disorders, and other related conditions?", "What is the effectiveness of tomography, emission-computed, single-photon, SPECT, SPET, and single photon emission tomography in detecting delirium, dementia, amnestic, cognitive disorders, including Alzheimer's disease, as well as primary progressive nonfluent aphasia, frontotemporal lobar degeneration, and progressive non-fluent aphasia in patients with conditions such as cerebral death, organic brain disease, organic brain syndrome, deteriorated cerebrum, and insufficient picking?", "What is the diagnostic accuracy of imaging techniques such as tomography, emission-computed, single-photon, SPECT, and SPET in detecting delirium, dementia, amnestic, cognitive disorders, and related conditions such as primary progressive nonfluent aphasia, FTD, FTLD, and neurological death?", "What is the effectiveness of diagnostic imaging and CT, SPECT, and SPET in detecting tomography, emitted-computed, single-photon, and SPECT/CT in patients with conditions such as delirium, dementia, amnestic, cognitive disorders, and mild brain death? Additionally, what are the benefits and drawbacks of these diagnostic imaging and CT, SPECT, and SPET studies in detecting these conditions, as compared to CT, SPECT, and SPET studies?", "What is the diagnostic accuracy of tomography, emission-computed, SPECT, SPET, and single photon emission tomography in detecting delirium, dementia, amnestic, cognitive disorders, including primary progressive non-fluent aphasia, frontotemporal lobar degeneration, and primary progressive aphasia in patients with conditions such as cerebrovascular disease, organic brain disease, organic brain syndrome, and deteriorating cognitive functions?", "What is the effectiveness of tomography, emission-computed, and imaging techniques such as SPECT, SPET, and single photon emission tomography in detecting delirium, dementia, amnestic, cognitive disorders, and frontotemporal lobar degeneration in patients with conditions such as primary progressive non-fluent aphasia, Delirium, Aphasia, or Frontotemporal lobar degeneration?", "What is the effectiveness of tomography, emission-computed, single-photon, SPECT, and SPET in detecting delirium, dementia, amnestic, cognitive disorders, such as primary progressive nonfluent aphasia, in elderly patients with conditions such as cerebral death, organic brain disease, organic brain syndrome, deterioration of the brain, insufficient picking, and lewy bodies?", "What is the diagnostic accuracy of tomography, emitted-computed, SPECT, and single photon emission tomography in detecting cognitive disorders such as delirium, dementia, amnestic, and primary progressive nonfluent aphasia?", "What is the diagnostic accuracy of imaging techniques such as tomography, emission-computed, SPECT, and SPET in detecting delirium, dementia, amnestic, cognitive disorders, including frontotemporal lobar degeneration, primary progressive nonfluent aphasia, and dementia?", "What is the diagnostic accuracy of imaging studies such as tomography, emission-computed, SPECT, and SPET in detecting delirium, dementia, amnestic, cognitive disorders, and other related terms in patients with conditions such as primary progressive nonfluent aphasia, Frontotemporal lobar degeneration, and progressive non-fluent aphasia?"]}
{"id": "CD010023", "boolean": "(Magnetic Resonance Imaging[mesh] OR (MRI[Text Word] OR MRIs[Text Word] OR NMRI[Text Word]) OR (diffusion weighted imag*[Text Word] OR DWI[Text Word] OR T2-weighted imag*[Text Word]) OR ((magnetic resonance[Text Word] OR MR[Text Word] OR NMR[Text Word]) AND (imag*[Text Word] OR tomograph*[Text Word] OR scan*[Text Word]))) AND (Radionuclide Imaging[mesh:noexp] OR scintiscan*[Text Word] OR (scintigra*[Text Word] OR radioscintigra*[Text Word]) OR (bone[Text Word] AND scan[Text Word])) AND (Tomography, X-Ray Computed[mesh] OR micro-computed tomog*[Text Word] OR (comput*[Text Word] AND tomograph*[Text Word]) OR (CT[Text Word] OR CAT[Text Word]))", "generated_query": ["What is the diagnostic accuracy of magnetic resonance imaging, diffusion weighted imaging, and other imaging modalities in detecting muscular and neurological disorders, such as Alzheimer's disease, in patients with suspected conditions, compared to CT, CAT, and tomography?", "What is the diagnostic accuracy of magnetic resonance imaging, diffusion weighted imaging, T2-weighted imaging, and other imaging modalities in detecting and staging lung cancer, including surgical resection and necrosis, in patients undergoing scintiscan, tomography, computed tomography, CT, CAT, or ultrasound?", "What is the diagnostic accuracy of magnetic resonance imaging, diffusion weighted imaging, T2-weighted imaging, and other imaging modalities in detecting fractures and bone lesions, including those in the spine, in patients with symptoms suggestive of fracture or bone lesions, as compared to computed tomography, x-ray computed, or micro-computed tomography?", "What is the diagnostic accuracy of magnetic resonance imaging, diffused weighted imaging, T2-weighted imaging, and tomography in detecting bone fractures and injuries, as compared to CT, CAT, or x-ray computed tomography in patients with conditions such as headache, spinal pain, and dizziness?", "What is the diagnostic accuracy of magnetic resonance imaging, including MRIs, NMRIs, and diffusion-weighted imaging, in detecting neurological death, brain death, and spinal death in patients with conditions such as cardio-pulmonary arrest, stroke, and intracranial hemorrhage?", "What is the diagnostic accuracy of magnetic resonance imaging, diffuse-weighted imaging, and other imaging modalities in detecting neurological death, brain death, cardiac death, and other medical conditions?", "What is the effectiveness of magnetic resonance imaging, MRI, and diffusion weighted imaging in detecting brain death in adult patients, as compared to radiologic tests such as CT, CAT, and micro-computed tomography?", "What is the diagnostic accuracy of magnetic resonance imaging, diffusion weighted imaging, and imaging modalities such as computed tomography, CT, and CAT in detecting bone injuries such as fractures, dislocations, and spinal disc ruptures?", "What is the diagnostic accuracy of magnetic resonance imaging, diffusion weighted imaging, and other imaging modalities in detecting and characterizing tumors, including those of the brain, breast, and prostate, as compared to CT, CAT, or micro-computed tomography in studies published in the last decade?", "What is the effectiveness of magnetic resonance imaging, diffusion weighted imaging, T2-weighted imaging, and radionuclide imaging in detecting cancer and tumors, as compared to tomography, x-ray computed, micro-computed tomography, and CT in studies published between 2008 and 2012?"]}
{"id": "CD010772", "boolean": "(IQCODE[tiab]) OR (\"informant questionnaire on cognitive decline in the elderly\"[tiab]) OR (\"IQ code\"[tiab]) OR ((\"informant* questionnair*\"[tiab] AND (dement*[tiab] OR screening[tiab]))) OR ((\"screening test*\"[tiab] AND (dement*[tiab] OR alzheimer*[tiab])))", "generated_query": ["What screening tests or informant questions are effective for detecting cognitive decline or dementia in elderly individuals, including those who may have pre-existing conditions such as Alzheimer's disease, and what are the most effective screening tests or informant questions for detecting cognitive decline or dementia in elderly individuals?", "What are the most effective screening tests or informant questions for detecting cognitive decline or Alzheimer's disease in elderly individuals, including the IQCODE, other screening tests, and screening interviews, in terms of accuracy, reliability, cost-effectiveness, and screening speed?", "What are the most effective screening tests or informant questionnaires for detecting cognitive decline or Alzheimer's disease in elderly individuals, including the IQCODE, the ACE-R, the Mini-Mental State Examination, and other screening tests, as compared in terms of accuracy and cost-effectiveness?", "What screening tests or informant questions are effective for detecting cognitive decline or dementia in elderly individuals, including those who may be asymptomatic or have mild symptoms? The IQCODE screening tests and informant questions are designed to detect cognitive decline or dementia in elderly individuals, as well as screen for Alzheimer's disease, and are used in studies on aging and elderly care.", "What are the most effective screening tests or informant questionnaires for detecting cognitive decline or Alzheimer's disease in elderly individuals, including the IQCODE, the IQCODE Screening Test, and screening tests that utilize symptoms such as memory loss and confusion?", "What screening tests or informant questionnaires are effective for detecting cognitive decline or Alzheimer's disease in elderly individuals, including the IQCODE, ACT, and the screening tests developed by the National Institute on Aging, as compared in studies that screen for these conditions?", "What screening tests or informant questionnaires are effective for identifying cognitive decline or Alzheimer's disease in elderly individuals, including the IQCODE, the Screening Tests for Alzheimer's Disease, and other screening tests?", "What screening tests or informant questionnaires are effective for detecting cognitive decline or Alzheimer's disease in elderly individuals, including the IQCODE, other screening tests, and informant interviews?", "What screening tests and informant questions can be used to detect cognitive decline and dementia in elderly individuals, as well as screen for medications or treatments that may be beneficial?", "What are the most effective screening tests or informant questions for detecting cognitive decline or Alzheimer's disease in elderly individuals, as measured by the IQCODE, including screening tests, diagnosis, and prevention?"]}
{"id": "CD011145", "boolean": "(MMSE*[tiab]) OR (sMMSE[tiab]) OR (Folstein*[tiab]) OR (MiniMental[tiab]) OR (\"mini mental stat*\"[tiab])", "generated_query": ["What is the effectiveness of screening tests such as MMSE, sMMSE, Folstein, and mini mental status examination in identifying dementia, Alzheimer's disease, and other related terms?", "What is the effectiveness of screening tests, such as MMSE, sMMSE, Folstein, and mini mental tests, in identifying individuals with cognitive impairments?", "What is the effectiveness of screening tests for detecting Alzheimer's disease, such as the MMSE, sMMSE, Folstein, and mini mental stature, in identifying patients with mild cognitive impairment?", "What is the effectiveness of screening tests such as the MMSE, sMMSE, Folstein, and mini mental state examination in identifying patients with cognitive impairments, including dementia and Alzheimer's disease, as compared to placebo interventions or other screening tests, such as those for urinary tract infections?", "What is the effectiveness of screening tests, such as MMSE, sMMSE, Folstein, and mini mental status tests, in identifying Alzheimer's disease and mild cognitive impairment?", "What is the effectiveness of screening tests, such as MMSE, sMMSE, Folstein, and mini mental states, in identifying individuals at risk for Alzheimer's disease, as compared to placebo interventions, in randomized controlled trials?", "What are the most effective screening tests for detecting Alzheimer's disease, including the MMSE, sMMSE, Folstein, and mini mental statute, as compared to placebo or other screening tests?", "What are the most effective screening tests for detecting Alzheimer's disease, including those of the MMSE, Folsom, and mini-mental status, as compared to placebo interventions, for identifying and monitoring cognitive decline in patients with symptoms suggestive of Alzheimer's disease?", "What are the most effective screening tests or informal assessments for identifying patients with mild cognitive impairment (MMSE*[tiab]), including those with early-stage Alzheimer's disease (sMMSE[tiab]), and who are at risk of progression to dementia (Folstein*[tiab])?", "What is the effectiveness of screening tests, such as the MMSE, sMMSE, Folstein, or mini mental state examination, in identifying patients with cognitive impairment or dementia?"]}
{"id": "CD010705", "boolean": "((Mycobacterium tuberculosis[mesh:noexp] OR Tuberculosis, Pulmonary[mesh] OR Tuberculosis, Multidrug-Resistant[mesh] OR TB[Title/Abstract] OR tuberculosis[Title/Abstract] OR MDR-TB[Title/Abstract] OR XDR-TB[Title/Abstract])) AND (MTBDR*[tiab] OR (Genotype MTBDR*[tiab]))", "generated_query": ["What is the current evidence on the treatment and management of tuberculosis, including multidrug-resistant and MDR-TB strains, as well as any studies on the diagnosis and prevention of the disease?", "What is the current evidence on the treatment and management of tuberculosis, including multidrug-resistant and any studies on the diagnosis and prevention of the disease, as well as the research on the detection of the disease?", "What is the current evidence on the treatment and management of tuberculosis, including multidrug-resistant strains, and the diagnosis and prevention of the disease?", "What is the current evidence on the treatment and management of tuberculosis, including multidrug-resistant and any studies on the diagnosis and prevention of the disease, as well as the most effective diagnostic tests and antibiotics for treating the illness?", "What is the diagnostic accuracy of detecting tuberculosis, including multidrug-resistant and any studies on the diagnosis of the disease, in patients with symptoms suggestive of the disease, using the Mycobacterium tuberculosis, H37Rv, and MTBDR* tests?", "What is the current evidence on the diagnostic accuracy of detecting tuberculosis, including multidrug-resistant and any studies on the diagnosis and treatment of the disease, in terms of genotypes and detection methods?", "What is the current evidence on the treatment and management of tuberculosis, including multidrug-resistant and any studies on the diagnosis and prevention of the disease?", "What is the current evidence on the treatment and management of tuberculosis, including multidrug-resistant and any studies on the diagnosis and prevention of the disease, as well as any studies on the diagnosis and prevention of the disease, as well as any studies on the diagnosis and prevention of the disease, as well as any studies on the diagnosis and prevention of the disease, as well as any studies on the diagnosis and prevention of the disease, as well as any studies on the diagnosis and prevention of the disease, as well as any studies on the diagnosis and prevention of the disease, as well as any studies on the diagnosis and prevention of the disease, as well as any studies on the diagnosis and prevention of the disease, as well as any studies on the diagnosis and prevention of the disease, as well as any studies on the diagnosis and prevention of the disease, as well as any studies on the diagnosis and prevention of the disease, as well as any studies on the diagnosis and prevention of the disease, as well as any studies on the diagnosis and prevention of the disease, as well as any studies on the diagnosis and prevent", "What is the current evidence on the treatment and management of tuberculosis, including multidrug-resistant and any studies on the diagnosis and prevention of the disease, as well as the molecular genotyping of the bacterium Mycobacterium tuberculosis, in recent studies?"]}
{"id": "CD010633", "boolean": "(Lewy Body Disease[mesh:noexp] OR Lewy Bodies[mesh:noexp] OR dement*[Title/Abstract] OR (LDB[Title/Abstract] OR DLB[Title/Abstract] OR LBD[Title/Abstract]) OR (lewy*[Title/Abstract] AND bod*[Title/Abstract])) AND (Tomography, Emission-Computed, Single-Photon[mesh:noexp] OR Dopamine Plasma Membrane Transport Proteins[mesh:noexp] OR Dopaminergic Neurons[mesh:noexp] OR \"[11C]cocaine\"[Title/Abstract] OR SPET[Title/Abstract] OR \"single photon emission tomography\"[Title/Abstract] OR FP-CIT[Title/Abstract] OR \"123I-FP-CIT\"[Title/Abstract] OR SPECT[Title/Abstract] OR \"[99mTc]TRODAT-1\"[Title/Abstract] OR \"[123I]PE2I\"[Title/Abstract] OR \"[123I]altropane\"[Title/Abstract] OR \"[3H]WIN\"[Title/Abstract] OR \"[11C]dMP\"[Title/Abstract] OR DAT scan*[Title/Abstract] OR \"[11C]FE-CIT\"[Title/Abstract] OR \"dopamine transporter\"[Title/Abstract] OR DaTSCAN[Title/Abstract] OR \"[11C]altropane\"[Title/Abstract] OR \"single photon emission computed tomography\"[Title/Abstract] OR (\"123I-\u03b2-CIT\"[Title/Abstract] OR \"[123I]\u03b2-CIT\"[Title/Abstract] OR \"[123I]beta-CIT\"[Title/Abstract]) OR (\"[11C]/[18F]beta-CFT\"[Title/Abstract] OR \"[11C]/[18F]\u03b2-CFT\"[Title/Abstract]))", "generated_query": ["What is the diagnostic accuracy of tomography, emission-computed, single-photon, dopamine plasma membrane transport proteins, and imaging agents such as 11C, cocaine, and SPET in detecting Lewy body disease, dementia, and lewy bodies?", "What are the most effective diagnostic imaging and molecular imaging tests for detecting Lewy body disease, including Tomography, Emission-Computed, Single-Photon, Dopamine Plasma Membrane Transport Proteins, Dopaminergic Neurons, and other imaging modalities such as SPECT, CT, and ultrasound?", "What is the diagnostic accuracy of imaging agents such as LDB, DLB, and SPET, as compared to TEM, SPECT, and FP-CIT, in detecting lewy body disease, dementia, and brain death? Additionally, what is the effectiveness of the imaging agents such as 11C, cocaine, and SPET in detecting lewy body disease, as compared to TEM, SPECT, and FP-CIT, in studies on neurodegeneration, loss of neurons, and brain death?", "What is the diagnostic imaging and neurological tests for detecting Lewy body disease, including ultrasonography, CT, SPECT, and DA TSCAN, and how do they compare to the imaging and tests in detecting the disease, as well as detecting other neurological conditions such as dementia, lewy bodies, and dopamine transporters?", "What is the diagnostic accuracy of imaging techniques such as tomography, emission-computed, single-photon, dopeamine plasma membrane transport proteins, dopeaminergic neurons, 11C cocaine, SPECT, and other imaging modalities in detecting Lewy body disease and dementia, as compared to CT, MRI, or biopsy?", "What is the effectiveness of imaging techniques such as tomography, emission-computed, single-photon, and positron-emission tomography (PET) in detecting Lewy body disease (LBD), dementia, and lewy bodies? Additionally, do any of these imaging techniques detect dopamine plasma membrane transport proteins, dopaminergic neurons, or cocaine receptors, and what is the effectiveness of these imaging modalities in detecting these biomarkers?", "What are the diagnostic imaging and neurological tests most effective for detecting lewy body disease, dementia, and Alzheimer's disease? This includes studies on the use of tomography, emission-computed, single-photon, dopaimine plasma membrane transport proteins, dopamine neurons, cocaine, SPECT, FP-CIT, 123I-FP-CIT, SPECT, and 99mTc-TRODAT-1?", "What is the diagnostic accuracy of imaging techniques such as tomography, emissions-computed, single-photon, and various PET imaging agents such as cocaine, 11C, and 18F in detecting lewy body disease, dementia, LDB, and lewy bodies?", "What is the diagnostic accuracy of imaging agents such as Tomography, Emission-Computed, Single-Photon, Dopamine Plasma Membrane Transport Proteins, Dopaminergic Neurons, 11C-dMP, DAT scan, and 11C-FE-CIT in detecting Lewy Body Disease, dementia, and 11C-altropane in studies on the diagnosis of Alzheimer's disease, using imaging agents such as SPECT, 99mTc, and 123I-PE2I in the research on the detection of beta-amyloid imaging agents such as 11C and 18F, and the analysis of neurological death?", "What is the diagnostic imaging and neurobiological markers of lewy body disease, including the presence and development of dementia, as compared to healthy controls? Additionally, what is the effectiveness of neurological tests, such as those for Parkinson's disease, in detecting and diagnosing lewy body disease, and what are the radiological imaging and neurobiological markers of this disease? Finally, what is the diagnostic accuracy of neurological tests, including those for Parkinson's disease, and what is the effectiveness of imaging and neurobiological markers, including those for lewy body disease, in detecting and diagnosing this disease?"]}
{"id": "CD010173", "boolean": "(Carcinoma, squamous cell[mesh] OR Precancerous conditions[mesh] OR (tumor*[All Fields] OR tumour*[All Fields] OR cancer*[All Fields] OR carcinoma*[All Fields] OR carcinogen*[All Fields] OR neoplas*[All Fields] OR malignan*[All Fields] OR metasta*[All Fields] OR dysplas*[All Fields] OR lesion*[All Fields] OR ulcer*[All Fields]) OR (pre-cancer*[All Fields] OR precancer*[All Fields] OR premalignan*[All Fields] OR precursor*[All Fields] OR \"lichen planus\"[All Fields] OR leukoplakia[All Fields] OR \"submucous fibrosis\"[All Fields] OR candidiasis[All Fields] OR erythroplakia[All Fields] OR erythroplas*[All Fields] OR erythroleukoplakia[All Fields] OR hyperplas*[All Fields] OR hyperkeratos*[All Fields] OR (actinic[All Fields] AND keratosis[All Fields]))) AND (Cytodiagnosis[mesh:noexp] OR Saliva[mesh:noexp] OR Luminescent Agents[mesh] OR Light[mesh:noexp] OR Acetic acid[mesh:noexp] OR Tomography, Optical Coherence[mesh:noexp] OR Diagnosis, Oral[mesh:noexp] OR Cytophotometry[mesh:noexp] OR Luminescence[mesh] OR Tolonium chloride[mesh:noexp] OR Cytological techniques[mesh:noexp] OR Tumor Markers, Biological[mesh:noexp] OR Spectrometry, fluorescence[mesh:noexp] OR Physical examination[mesh:noexp] OR Fluorescence[mesh:noexp] OR Spectrophotometry[mesh:noexp] OR Mass screening[mesh:noexp] OR Coloring agents[mesh:noexp] OR lumenoscop*[All Fields] OR acetowhite[All Fields] OR (visual*[All Fields] AND (\"light emitting diode\"[All Fields] OR \"blue spectrum\"[All Fields] OR LED[All Fields] OR luminous*[All Fields])) OR ((analy*[All Fields] OR screen*[All Fields] OR test*[All Fields] OR examin*[All Fields]) AND (blood[All Fields] OR saliva[All Fields])) OR (brush*[All Fields] AND (cytodiagnosis[All Fields] OR cytopathology[All Fields])) OR (tissue[All Fields] AND reflect*[All Fields]) OR (brush[All Fields] AND biops*[All Fields]) OR (visual*[All Fields] AND (exam*[All Fields] OR inspect*[All Fields] OR screen*[All Fields])) OR (\"modified liquid based cytology\"[All Fields] OR (exfoliat*[All Fields] AND cytolog*[All Fields])) OR (\"tolonium chloride\"[All Fields] OR \"tolu* blue\"[All Fields] OR \"tolu* b\"[All Fields] OR tblue[All Fields] OR t-blue[All Fields]) OR ((tumor*[All Fields] OR tumour*[All Fields] OR cancer*[All Fields] OR carcinoma*[All Fields] OR neoplas*[All Fields] OR carcinogen*[All Fields] OR malignan*[All Fields] OR metata*[All Fields] OR lesion*[All Fields] OR ulcer*[All Fields]) AND (fluorescen*[All Fields] OR autofluorescen*[All Fields] OR luminescen*[All Fields] OR chemiluminescen*[All Fields])) OR (acetic acid[All Fields] AND (wash*[All Fields] OR rins*[All Fields])) OR ((\"tumo* marker*\"[All Fields] OR \"neoplas* marker*\"[All Fields]) AND (blood[All Fields] OR saliva[All Fields])) OR ((oral*[All Fields] OR mouth*[All Fields]) AND (exam*[All Fields] OR histolog*[All Fields] OR check*[All Fields] OR inspect*[All Fields])) OR (visuali*[All Fields] AND adjunct*[All Fields]) OR (vizilite[All Fields] OR microlux*[All Fields] OR orascoptic[All Fields] OR velscope[All Fields]) OR (\"oral cdx\"[All Fields] OR oralcdx[All Fields]) OR (tolu*[All Fields] AND (dye*[All Fields] OR rins*[All Fields] OR stain*[All Fields] OR wash*[All Fields]))) AND (Mouth neoplasms[mesh] OR Lichen Planus, Oral[mesh:noexp] OR Oral submucous fibrosis[mesh:noexp] OR Oral candidiasis[mesh:noexp] OR (oral*[All Fields] OR mouth*[All Fields] OR bucca*[All Fields] OR \"oral cavit*\"[All Fields] OR lip[All Fields] OR lips[All Fields] OR tongue*[All Fields] OR gingiv*[All Fields] OR palat*[All Fields] OR cheek*[All Fields] OR \"intra oral*\"[All Fields] OR intraoral*[All Fields] OR gum[All Fields] OR gums[All Fields] OR labial*[All Fields] OR (oral[All Fields] AND mucosa*[All Fields]) OR (mouth[All Fields] AND mucosa*[All Fields])) AND (tumor*[All Fields] OR tumour*[All Fields] OR cancer*[All Fields] OR carcinoma*[All Fields] OR carcinogen*[All Fields] OR neoplas*[All Fields] OR malignan*[All Fields] OR metasta*[All Fields] OR dysplas*[All Fields] OR lesion*[All Fields] OR ulcer*[All Fields] OR pre-cancer*[All Fields] OR precancer*[All Fields] OR premalignan*[All Fields] OR precursor*[All Fields] OR \"lichen planus\"[All Fields] OR leukoplakia[All Fields] OR \"submucous fibrosis\"[All Fields] OR candidiasis[All Fields] OR erythroplakia[All Fields] OR erythroplas*[All Fields] OR erythroleukoplakia[All Fields] OR hyperplas*[All Fields] OR hyperkerato*[All Fields] OR (actinic[All Fields] AND keratosis[All Fields])))", "generated_query": ["What is the diagnostic accuracy of cytodiagnosis, saliva, and luminous agents in detecting oral neoplasms, such as lichen planus, oral submucous fibrosis, and erythroplakia, as compared to visual examination and biopsy?", "What is the diagnostic accuracy of cytodiagnosis, saliva, luminescent agents, light, acetic acid, and tomography, optical coherence, in detecting neoplasms such as lichen planus, leukoplakia, erythroplakia, and dysplasias in patients with symptoms suggestive of oral cavities, intraoral mucosa, and oral mucosa?", "What is the effectiveness of diagnostic imaging and screening tests, including Cytodiagnosis, Saliva, Luminescent Agents, Light, Acetic acid, Tomography, Optical Coherence, Diagnosis, Oral, Cytophotometry, Luminescence, Tolonium chloride, Cytological techniques, Tissue, and Modified Liquid Based Cytology, in detecting oral neoplasms, lichen planus, leukoplakia, submucous fibrosis, candidiasis, erythroplas*, erythrome, and hyperplas*, including those with metastatic, dysplastic, lesional, ulcer, premalignan*, precursor, and inhibitory characteristics?", "What is the effectiveness of various screening and diagnostic tests, including those that utilize cytodiagnosis, saliva, luminescent agents, light, acetic acid, and tomography, Optical Coherence, Diagnosis, Oral, Cytopathology, and toluene blue, in detecting oral neoplasms such as lichen planus, leukoplakia, and submucious fibrosis, as compared to screening methods such as mammography, ultrasonography, and fluorescence imaging?", "What is the effectiveness of diagnostic tests, such as cytodiagnosis, saliva, and luminescent agents, in detecting oral neoplasms such as lichen planus, oral submucous fibrosis, and dysplasia, in patients with lesions, ulcers, ulcrums, and ulcerative conditions? Additionally, what is the diagnostic accuracy of acetic acid, toluene blue, and light-emitting diodes in detecting these conditions, as compared to conventional tests such as visual inspection and biopsy, in patients with lesional conditions such as ulcers and ulcus?", "What is the effectiveness of screening methods, such as cytodiagnosis, tomography, and lumenoscopy, in detecting oral neoplasms such as lichen planus, leukoplakia, dysplasia, and ulcers, as well as pre-cancerous conditions such as actinic keratosis, erythroplakia, and neoplasms, in patients with symptoms suggestive of lesions, ulcers, or ulcular disorders? Additionally, what is the diagnostic accuracy of acetic acid, toluene blue, and lumenography in detecting oral neoplasms, including those that are pre-cancerous, and what are the tumor markers, biological tests, and screening methods that are effective in detecting these conditions?", "What is the diagnostic accuracy of cytodiagnosis, saliva, luminous agents, and other screening tests for detecting mouth neoplasms such as lichen planus, leukoplakia, and submucous fibrosis?", "What is the diagnostic accuracy of screening methods, such as cytodiagnosis, saliva, luminescent agents, light, acetic acid, tomography, optical coherence, diagnostic markers, and imaging modalities in detecting oral neoplasms such as lichen planus, leukoplakia, and erythroplakia?", "What is the effectiveness of cytodiagnosis, saliva, lumenoscopy, and screening tests in detecting oral neoplasms such as lichen planus, erythroplakia, and sub-mucous fibrosis? Additionally, what are the tumor markers, biological tests, and oral cavity screening tests that are effective in detecting these neoplasms, including acetic acid, toluene, dye, rins, stain, wash, and mucosa-targeted tests? Finally, what are the visualization methods and diagnostic tests that can be used to detect these neoplasms, including fluorescent markers, metallic particles, CT, MRI, ultrasound, and biological markers?", "What is the diagnostic accuracy of screening tests, oral examinations, visual aids, coloring agents, lumenoscopic procedures, toluene, and cytodiagnosis in detecting mouth neoplasms such as lichen planus, leukoplakia, and dysplasia, as compared to surgical biopsy and pathologic examination, in patients with pre-cancerous conditions, tumors, cancers, carcinomas, neoplasms, malignancies, metastases, dysplasias, lesions, ulcers, and pre-cancerous conditions?"]}
{"id": "CD009786", "boolean": "(Ovarian Neoplasms[mesh] OR Fallopian Tube Neoplasms[mesh:noexp] OR ((ovar*[All Fields] OR fallopian tube*[All Fields]) AND (cancer*[All Fields] OR tumor*[All Fields] OR tumour*[All Fields] OR adenocarcinoma*[All Fields] OR carcino*[All Fields] OR cystadenocarcinoma*[All Fields] OR choriocarcinoma*[All Fields] OR malignan*[All Fields] OR neoplas*[All Fields] OR metasta*[All Fields] OR mass[All Fields] OR masses[All Fields])) OR (thecoma*[All Fields] OR luteoma*[All Fields])) AND (Laparoscopy[mesh] OR laparoscop*[All Fields] OR celioscop*[All Fields] OR peritoneoscop*[All Fields] OR abdominoscop*[All Fields])", "generated_query": ["What is the effectiveness of ovarian, fallopian tube, and laparoscopic surgical procedures in treating ovarian neoplasms, including adenocarcinoma, choriocarcinoma, malignan, neoplasms, metasta, masses, and thecoma, as well as laparoscopic surgical procedures such as cystadenocarcinoma, dyeing, surgical intervention, surgical procedures, and laparoscopic procedures?", "What is the effectiveness of laparoscopic surgical procedures, such as ovary neoplasms, fallopian tube neoplasms, adenocarcinoma, carcino, cystadenocarcinoma, choriocarcinoma, malignan, neoplasms, thecoma, luteoma, and peritoneoscopy, in treating conditions such as cysts, tumors, adenomas, and metastasis?", "What is the diagnostic accuracy of ovarian, fallopian tube, and adenocarcinoma surgical procedures such as laparoscopic surgery, celioscopy, and peritoneoscopy in detecting ovarian, fallopian tube, and adenocarcinoma metastasis, cysts, or tumors?", "What is the effectiveness of laparoscopic surgical procedures, including cystadeno- and choriocarcinoma, malignancies, adenocarcinoma, carcino, cystadenoma, chorioma, and metastasis, in treating ovarian, fallopian tube, and adenocarcinoma?", "What is the effectiveness of ovarian, fallopian tube, and adenocarcinoma surgical interventions, including laparoscopy, laparoscop*, celioscopy, peritoneoscopy, and abdominoscopy, in treating neoplasms, adenocarcinoma, tumors, cancers, and metastasis?", "What is the effectiveness of ovarian, fallopian tube, and adenocarcinoma treatments, including laparoscopy, celioscopy, and peritoneoscopy, in patients with symptoms suggestive of tumors, cancers, metastasis, or adenocarcinoma?", "What is the effectiveness of laparoscopic surgical procedures such as ovary, fallopian tube, and adenocarcinoma surgery in treating ovarian, fallopian tube, and adenocarcinoma tumors, as well as cystadenocarcinoma, choriocarcinoma, malignancies, and metastasis, in patients with symptoms suggestive of ovarian or fallopian tube cancer?", "What is the effectiveness of laparoscopic surgical procedures, including cystoduodenectomy and pancreatectomy, pancreatectomy, pancreatectomy, pancreatectomy, pancreatectomy, pancreatectomy, pancreatectomy, pancreatectomy, pancreatectomy, pancreatectomy, pancreatectomy, pancreatectomy, pancreatectomy, pancreatectomy, pancreatectomy, pancreatectomy, pancreatectomy, pancreatectomy, pancreatectomy, pancreatectomy, pancreatectomy, pancreatectomy, pancreatectomy, pancreatectomy, pancreatectomy, pancreatectomy, pancreatectomy, pancreatectomy, pancreatectomy, pancreatectomy, pancreatectomy, pancreatectomy, pancreatectomy, pancreatectomy, pancreatectomy, pancreatectomy, pancreatectomy, pancreatectomy, pancreatectomy, pancreatectomy, pancreatectomy, pancreatectomy, pancreatectomy, pancreatectomy, pancreatectomy, pancreatectomy, pancreatect", "What is the effectiveness of laparoscopic surgical procedures, such as cystectomy, cholecystomy, pancreatectomy, pancreatectomy with pancreaticojejunostomy, pancreatectomy with pancreaticojejunostomy, pancreaticojejunostomy, pancreatectomy, pancreaticojejunostomy, pancreaticojejunostomy, pancreaticojejunostomy, pancreaticojejunostomy, pancreaticojejunostomy, pancreaticojejunostomy, pancreaticojejunostomy, pancreaticojejunostomy, pancreaticojejunostomy, pancreaticojejunostomy, pancreaticojejunostomy, pancreaticojejunostomy, pancreaticojejunostomy, pancreaticojejunostomy, pancreaticojejunostomy, pancreaticojejunostomy, pancreaticojejunostomy, pancreaticojejunost", "What is the effectiveness of laparoscopic surgical procedures, including ovary, fallopian tube, adenocarcinoma, and choriocarcinoma, in treating conditions related to ovarian, fallopian tube, and adenocarcinoma, as well as metastasis, masses, cysts, and adenomegaly?"]}
{"id": "CD010386", "boolean": "(Positron-Emission Tomography[mesh:noexp] OR \"C Pittsburgh\"[Title/Abstract] OR \"amyloid deposition\"[Title/Abstract] OR \"[11C]PIB\"[Title/Abstract] OR \"Pittsburgh compound B\"[Title/Abstract] OR \"amyloid ligand*\"[Title/Abstract] OR (PiB[Title/Abstract] OR PIB[Title/Abstract]) OR (PIB-PET[Title/Abstract] OR PET-PIB[Title/Abstract]) OR (\"positron emission tomography\"[Title/Abstract] OR (PET[Title/Abstract] AND (scan*[Title/Abstract] OR imag*[Title/Abstract])))) AND (dementia[mesh] OR LCD[Title/Abstract] OR MNCD[Title/Abstract] OR MCI[Title/Abstract] OR CIND[Title/Abstract] OR AAMI[Title/Abstract] OR MCD[Title/Abstract] OR ARCD[Title/Abstract] OR BSF[Title/Abstract] OR QD[Title/Abstract] OR AACD[Title/Abstract] OR ACMI[Title/Abstract] OR SMC[Title/Abstract] OR (\"CDR 0.5\"[Title/Abstract] OR \"clinical dementia rating scale 0.5\"[Title/Abstract] OR \"0.5 CDR\"[Title/Abstract]) OR (nMCI[Title/Abstract] OR aMCI[Title/Abstract] OR mMCI[Title/Abstract]) OR (\"GDS 3\"[Title/Abstract] OR \"3 GDS\"[Title/Abstract]) OR ((cognit*[Title/Abstract] OR memory[Title/Abstract] OR cerebr*[Title/Abstract] OR mental*[Title/Abstract]) AND (declin*[Title/Abstract] OR impair*[Title/Abstract] OR los*[Title/Abstract] OR deteriorat*[Title/Abstract] OR degenerat*[Title/Abstract] OR complain*[Title/Abstract] OR disturb*[Title/Abstract] OR disorder*[Title/Abstract])) OR (\"N-MCI\"[Title/Abstract] OR \"A-MCI\"[Title/Abstract] OR \"M-MCI\"[Title/Abstract]) OR (alzheimer*[Title/Abstract] OR dement*[Title/Abstract] OR AD[Title/Abstract] OR lewy*[Title/Abstract] OR DLB[Title/Abstract] OR LBD[Title/Abstract]) OR (\"global deterioration scale\"[Title/Abstract] AND \"stage 3\"[Title/Abstract]))", "generated_query": ["What is the diagnostic accuracy of imaging agents such as Positron-Emission Tomography, C Pittsburgh, amyloid deposition, and PiB in detecting dementia, including Alzheimer's disease, lewy bodies, and dlb, in studies of memory and cognitive impairment?", "What is the diagnostic accuracy of positron-emission tomography, C Pittsburgh, amyloid deposition, 11C-PIB, Pittsburgh compound B, amyloid ligand, and imaging agents such as PiB in detecting Alzheimer's disease, LCD, MNCD, and MCI in studies involving individuals with complaints, disturbances, or disorders of memory, cognition, cerebration, or mental health?", "What is the diagnostic accuracy of imaging agents such as positron-emission tomography (PET), C Pittsburgh, amyloid deposition, and 11C-PiB in detecting dementia, LCD, MNCD, MCI, CIND, AAMI, and mCD in studies that utilize the cognitive decline index, deterioration index, or global deterioration scale as markers?", "What is the diagnostic accuracy of positron-emission tomography (PET), C Pittsburgh, amyloid deposition, 11C-PIB, and Pittsburgh compound B in detecting dementia, LCD, MNCD, MCI, CIND, AAMI, and MCD?", "What is the effectiveness of Positron-Emission Tomography (PET-PiB), Amyloid imaging, and other imaging modalities in the diagnosis of dementia, LCD, MNCD, AAMI, MCD, ARCD, BSF, QD, AACD, and ACMI, in patients with clinical features suggestive of Alzheimer's disease, including amyloid deposition, 11C-PIB, Pittsburgh compound B, amyloid ligand, PiB, and AAMI? Additionally, what are the characteristics of the imaging studies and diagnostic tests that are most effective in detecting Alzheimer's disease, including cognitive decline, memory loss, cerebral death, and clinical dementia rating scale, in patients with symptoms suggestive of Alzheimer's disease, such as deterioration in speech, decline in mental acuity, and inability to recognize faces?", "What is the diagnostic accuracy of imaging agents such as PET, C Pittsburgh, 11CPIB, PIB-PET, and positron-emission tomography in detecting Alzheimer's disease, including early stages such as LCD, MNCD, AAMI, MCD, and ARCD, as measured by the CDR 0.5 and clinical dementia rating scale 0.5, in patients with complaints of cognitive decline, impairment, loss, deterioration, or degeneration?", "What is the diagnostic accuracy of Positron-Emission Tomography, C Pittsburgh, amyloid deposition, 11C PIB, and Pittsburgh compound B in detecting dementia, LCD, MNCD, AAMI, and MCD, in patients with neurological diseases such as Alzheimer's, lewy, DLB, AAMI, and MCD?", "What is the diagnostic accuracy of imaging agents such as Positron-Emission Tomography, C Pittsburgh, amyloid deposition, and other imaging modalities in detecting dementia, Alzheimer's disease, and related disorders such as LCD, MNCD, and MCI? Additionally, what are the benefits and drawbacks of these imaging agents, and what are the most effective diagnostic tests for detecting these conditions?", "What is the diagnostic accuracy of positron-emission tomography (PET-PIB, C Pittsburgh, 11C PIB, and PiB), amyloid imaging agents such as AAMI, and clinical dementia rating scales such as ARCD, BSF, and GDS in detecting dementia, LCD, MNCD, MCI, CIND, AAMI, and mMCI?", "What is the diagnostic accuracy of positron-emission tomography, C Pittsburgh, amyloid deposition, 11CPIB, and other imaging modalities in detecting dementia, LCD, MNCD, and MCI in patients with symptoms suggestive of Alzheimer's disease? Additionally, what is the effectiveness of these imaging modalities in identifying neuropsychological deficits, such as those related to memory, cerebral cortex, mental status, and cognitive decline, in patients with symptoms suggestive of Alzheimer's disease? Finally, what is the effectiveness of these imaging modalities in detecting the presence of amyloid deposition, 11CPIB, and Pittsburgh compound B in patients with symptoms suggestive of Alzheimer's disease?"]}
{"id": "CD010783", "boolean": "MMSE*[Tiab] OR OR sMMSE[Tiab] OR Folstein*[Tiab] OR MiniMental[Tiab] OR \"mini mental stat*\"[Tiab]", "generated_query": ["What is the effectiveness of screening tests for dementia, including the MMSE, sMMSE, and Folstein tests, in identifying individuals with cognitive decline or memory loss, as well as mini-mental tests, in assessing the cognitive status of these individuals?", "What is the effectiveness of screening tests, such as the MMSE, sMMSE, and Folstein, in identifying mild cognitive impairment, as well as dementia and Alzheimer's disease, in older adults?", "What is the effectiveness of screening tests such as MMSE, sMMSE, Folstein, MiniMental, and mini mental stat in identifying patients with mild cognitive impairment, including those in the earliest stages of Alzheimer's disease, as compared to placebo interventions or other screening tests, in studies published between 1986 and 2016?", "What are the most effective screening tests for identifying Alzheimer's disease, including the MMSE, sMMSE, Folstein, and mini mental tests, and how do they compare in terms of accuracy and cost-effectiveness?", "What is the effectiveness of screening tests such as the MMSE, sMMSE, Folstein, and mini mental status exam in identifying patients with cognitive impairment, including Alzheimer's disease, in elderly patients?", "What is the effectiveness of screening tests, such as the MMSE, sMMSE, Folstein, and mini-mental status exam, in detecting cognitive impairment or dementia in elderly patients?", "What is the effectiveness of screening tests such as the MMSE, sMMSE, Folstein, and mini mental tests in detecting Alzheimer's disease, mild cognitive impairment, and other related disorders?", "What is the effectiveness of the MMSE, sMMSE, Folstein, and mini mental tests in identifying mild cognitive impairment (MCI), Alzheimer's disease, and other related disorders in patients with complaints suggestive of memory loss, disorientation, or other cognitive impairments?", "What are the most effective screening tests or screening instruments for identifying mild cognitive impairment (MCI), Alzheimer's disease, and other related conditions in older individuals? Specifically, I am interested in studies that investigate the use of the MMSE, sMMSE, Folstein, and mini-mental state exam in screening for these conditions, as well as studies that investigate the effectiveness of alternative screening tests such as those developed by Dr. Larry Silverberg?", "What is the effectiveness of screening tests, such as MMSE, sMMSE, Folstein, and mini mental state, in detecting dementia or cognitive decline?"]}
{"id": "CD010860", "boolean": "(MCE[Tiab] and (cognit*[Tiab] OR dement*[Tiab] OR screen*[Tiab] OR Alzheimer[Tiab])) OR minicog[Tiab] OR mini-Cog[Tiab]", "generated_query": ["What is the effectiveness of MCE, cognitive screening tests, and Alzheimer's disease screening tests in detecting cognitive impairment or dementia in patients with complaints of memory loss, confusion, and other related symptoms?", "What is the effectiveness of using MCE, cognitive stimulation therapy, or Alzheimer's disease screening in identifying individuals with dementia, cognitive decline, or Alzheimer's disease?", "What is the effectiveness of mce, cognitive, and Alzheimer's disease screening tests in identifying and diagnosing cognitive impairments such as dementia and screening for Alzheimer's disease?", "What is the effectiveness of MCE, cognitive training, and Alzheimer's disease screening tests in detecting mild cognitive impairment or dementia, as compared to placebo interventions or other screening tests, in studies published between 1999 and 2019?", "What is the effectiveness of medical cognitive examination (MCE), including mini-cog tests, Alzheimer's screening, and cognitive screening, in identifying neurological and cognitive disorders, such as Alzheimer's disease, mild cognitive impairment, and screen tests, in patients with symptoms suggestive of these disorders?", "What is the effectiveness of the MCE, cognitive screening, and Alzheimer's disease screening tests in identifying patients with neurodegeneration, dementia, and Alzheimer's disease?", "What is the effectiveness of the MCE, cognitive, and Alzheimer's tests in identifying and screening individuals for dementia, as compared to placebo interventions or other screening tests, in studies published between 1989 and 2019?", "What is the effectiveness of using MCE, cognitive screening, or Alzheimer's disease screening in identifying individuals with mild cognitive impairment, dementia, or Alzheimer's disease?", "What is the effectiveness of using MCE, cognitive models, or screening tests in detecting Alzheimer's disease?", "What is the effectiveness of using MCE, cognitive assessment, screening, or Alzheimer's disease screening tests in identifying and assessing cognitive impairment or dementia in individuals with symptoms suggestive of Alzheimer's disease?"]}
{"id": "CD009579", "boolean": "(Antigens, Helminth[mesh] OR Glycoproteins[mesh] OR Helminth Proteins[mesh] OR Reagent Strips[mesh] OR Schistosoma haematobium[mesh] OR Enzyme-Linked Immunosorbent Assay[mesh] OR Antibodies, Monoclonal[mesh] OR hematuria[mesh:noexp] OR proteinuria[mesh] OR Immunoenzyme Techniques[mesh] OR Schistosoma mansoni[mesh] OR h*[Title/Abstract] OR elisa[Title/Abstract] OR albuminuria[Title/Abstract] OR dipstick[All Fields] OR CCA[Title/Abstract] OR leucocyturia[Title/Abstract] OR CAA[Title/Abstract] OR leukocyturia[Title/Abstract] OR proteinuria[Title/Abstract] OR haemastix[Title/Abstract] OR eia[Title/Abstract] OR \"schistosoma haematobium\"[Title/Abstract] OR urinalysis[Title/Abstract] OR \"schistosoma mansoni\"[Title/Abstract] OR (reagent[Title/Abstract] AND strip*[Title/Abstract]) OR (test[Title/Abstract] AND strip*[Title/Abstract]) OR (anodic[Title/Abstract] AND antigen*[Title/Abstract]) OR (cathodic[Title/Abstract] AND antigen*[Title/Abstract])) AND (schistosomiasis[mesh:noexp] OR schistosomiasis haematobia[mesh:noexp] OR schistosomiasis mansoni[mesh:noexp] OR schistosomiasis[Title/Abstract] OR bilharzia*[Title/Abstract])", "generated_query": ["What is the diagnostic accuracy of immunoenzyme techniques, such as ELISA, CCA, leucocyturia, and dipsticks, in detecting schistosoma haematobium, Enzyme-Linked Immunosorbent Assay, antibodies, monoclonal, and immunoenzyme tests, as compared to urinalysis, reagent strips, and dipsticks, in detecting schistosomiasis, including Bilharzia, and detecting Enzyme-Linked Immunosorbent Assay, antibodies, monoclonal, and immunoenzyme tests, as compared to urinalysis, reagent strips, and dipsticks, in detecting schistosomiasis, including Bilharzia, and detecting Enzyme-Linked Immunosorbent Assay, antibodies, monoclonal, and immunoenzyme tests, as compared to urinalysis, reagent strips, and dipsticks, in detecting schistosomiasis, including Bilharzia, and detecting Enzyme-Linked Immunosorbent Assay", "What are the most effective diagnostic tests for detecting schistosomiasis, including Enzyme-Linked Immunosorbent Assay, antibodies, monoclonal, hematuria, proteinuria, immunoenzyme techniques, Schistosoma mansoni, and reagent strips?", "What is the effectiveness of diagnostic tests, such as Enzyme-Linked Immunosorbent Assay, antibodies, monoclonal, and immunoenzyme techniques, for detecting Schistosoma haematobium or Enzyme-Linked Immunosorbent Assay, in urine, immunoenzyme techniques, CCA, and leucocyturia, compared to reagent strips, dipsticks, or eia?", "What is the diagnostic accuracy of antigen detection, glycoproteins, enzyme-linked immunosorbent assay, monoclonal antibodies, hematuria, proteinuria, immunoenzyme techniques, Schistosoma mansoni, HIV, AIDS, and reagent strips in detecting schistosomiasis, including urinary antigen tests, dipsticks, CCA, and leucocyturia?", "What is the diagnostic accuracy of immunoenzyme techniques, including Elissa, antibodies, monoclonal, hematuria, proteinuria, and reagent strips, in detecting schistosomiasis caused by Schistosoma haematobium, Enzyme-Linked Immunosorbent Assay, CCA, leucocyturia, and albuminuria?", "What is the diagnostic accuracy of antigens, glycoproteins, helminth proteins, reagent strips, schistosoma haematobium, Enzyme-Linked Immunosorbent Assay, Antibodies, Monoclonal, hematuria, proteinuria, immunoenzyme techniques, Schistosoma mansoni, h*, elfa, albuminuria, dipsticks, CCA, leucocyturia, CAA, leukocyturia, proteinuria, haemastix, eia, schistosoma haematobium, urinalysis, schistosoma mansoni, reagent, test, anodic, cathodic, eia, immunoenzyme techniques, and Enzyme-Linked Immunosorbent Assay in detecting schistosomiasis, including urinary and blood tests, as well as diagnostic reagent strips, from January 2004 to December 2014?", "What is the effectiveness of various diagnostic tests, including immunoenzyme techniques, antigen-antibody reactions, reagent strips, Schistosoma haematobium, and Enzyme-Linked Immunosorbent Assay, in detecting schistosomiasis?", "What is the diagnostic accuracy of various immunodiagnostic tests, including Enzyme-Linked Immunosorbent Assay, Monoclonal Antibodies, Reagent Strips, Schistosoma haematobium, Enzyme-Linked Immunosorbent Assay, and Antibodies, for detecting schistosomiasis, including hematobia and mansoni, as well as dipsticks, CCA, and leucocyturia, in urine or blood?", "What is the diagnostic accuracy of various tests, including antigens, glycoproteins, reagent strips, Schistosoma haematobium, and enzyme-linked immunosorbent assay, in detecting schistosomiasis, including urinalysis and eia, as compared to dipsticks, CCA, leucocyturia, CAA, leukocyturia, proteinuria, and haemastix?", "What is the effectiveness of diagnostic tests, including antibodies, monoclonal, and reagent strips, for detecting schistosomiasis caused by S. haematobium or E. coli?"]}
{"id": "CD009925", "boolean": "(chorionic villi sampling[mesh:noexp] OR INHIBINS[mesh] OR alpha-Fetoproteins[mesh] OR Chorionic Gonadotropin, beta Subunit, Human[mesh] OR Area under curve[mesh:noexp] OR amniocentesis[mesh:noexp] OR false positive reactions[mesh] OR Prenatal Diagnosis[mesh] OR false negative reactions[mesh] OR Pregnancy-Associated Plasma Protein-A[mesh] OR ROC curve[mesh:noexp] OR papp-a[All Fields] OR human chorionic gonadotropin[All Fields] OR inhibin a[All Fields] OR diagnos*[Title/Abstract] OR accura*[All Fields] OR AUC[All Fields] OR ultrasound[All Fields] OR marker*[All Fields] OR tricuspid regurgitation[All Fields] OR specific*[All Fields] OR \"reproducibility of results\"[All Fields] OR predict*[All Fields] OR sensitiv*[All Fields] OR reference standard*[All Fields] OR afp[All Fields] OR screen*[All Fields] OR detect*[All Fields] OR reference value*[All Fields] OR pregnancy associated plasma protein a[All Fields] OR ue3[All Fields] OR chorion* vill* sampling[All Fields] OR ROC[All Fields] OR nuchal translucency[All Fields] OR ductus venosus[All Fields] OR likelihood ratio*[All Fields] OR alphafetoprotein*[All Fields] OR alpha-fetoprotein*[All Fields] OR nasal bone[All Fields] OR (b-hcg[All Fields] OR bhcg[All Fields]) OR (unconjugated estriol[All Fields] OR unconjugated oestriol[All Fields]) OR (false positive*[All Fields] OR false negative*[All Fields])) AND (Aneuploidy[mesh:noexp] OR Mosaicism[mesh:noexp] OR Down Syndrome[mesh] OR down syndrome[All Fields] OR trisomy 21[All Fields] OR aneuploidy[All Fields] OR mosaicism[All Fields] OR downs syndrome[All Fields])", "generated_query": ["What is the accuracy, reliability, and specificity of prenatal diagnostic markers such as chorionic villi sampling, amniocentesis, ultrasound, and various biomarkers such as inhibins, alpha-fetoproteins, and human chorionic gonadotropin? Additionally, what is the diagnostic value of markers such as nuchal translucency, nasal bone, and tricuspid regurgitation, and what is the reproducibility of results and reference values for these markers? Finally, what is the sensitivity and specificity of these markers, as measured in terms of positive and negative likelihood ratios, area under the ROC curve, and papp-a, in detecting aneuploidy and mosaicism, particularly Down syndrome?", "What is the accuracy and reliability of prenatal diagnostic markers, such as chorionic villi sampling, amniocentesis, ultrasound, and various biomarkers including inhibins, alpha-fetoproteins, and human chorionic gonadotropin, in detecting aneuploidy, mosaicism, and Down syndrome? Additionally, what is the reproducibility of results, reference values, pregnancy-associated plasma protein A, and area under the ROC curve of these markers, and how do false positive and false negative reactions affect their sensitivity and specificity?", "What is the accuracy and reliability of prenatal diagnostic markers, such as chorionic villi sampling, amniocentesis, ultrasound, and various biomarkers including inhibins, alpha-fetoproteins, and human chorionic gonadotropin, in detecting aneuploidy, mosaicism, and Down syndrome? Additionally, what is the diagnostic value of specific markers such as nuchal translucency, nasal bone, and tricuspid regurgitation? Finally, what is the predictive value of these markers, as measured in sensitivity, specificity, likelihood ratios, and area under the ROC curve, and what is the reproducibility of results?", "What is the accuracy, reliability, and predictive value of prenatal diagnostic markers, such as chorionic villi sampling, amniocentesis, ultrasound, and various biomarkers including inhibins, alpha-fetoproteins, and human chorionic gonadotropin, in detecting aneuploidy? Additionally, what is the diagnostic value of specific markers such as nuchal translucency, nasal bone, and tricuspid regurgitation? Finally, what is the reproducibility of results and reference values for these markers, as measured in sensitivity, specificity, likelihood ratios, and area under the ROC curve?", "What is the accuracy and reliability of prenatal diagnostic markers, such as chorionic villi sampling, amniocentesis, ultrasound, and various biomarkers including inhibins, alpha-fetoproteins, and human chorionic gonadotropin, in detecting aneuploidy, mosaicism, and Down syndrome? Additionally, what is the reproducibility of results and reference values for these markers, and how do false positive and false negative reactions affect their sensitivity and specificity? Finally, what is the predictive value of these markers, as measured by sensitivity, likelihood ratios, and area under the ROC curve, and how do they compare to other markers such as nuchal translucency, nasal bone, and tricuspid regurgitation?", "What is the accuracy and reliability of prenatal diagnostic markers such as chorionic villi sampling, amniocentesis, ultrasound, and various biomarkers including inhibins, alpha-fetoproteins, and human chorionic gonadotropin in detecting aneuploidy, mosaicism, and Down syndrome? Additionally, what is the reproducibility of results and reference values for these markers, and how do false positive and false negative reactions affect their sensitivity and specificity? Finally, what is the predictive value of these markers, as measured by likelihood ratios, and how do they compare to the area under the ROC curve?", "What is the accuracy and reliability of prenatal diagnostic markers, such as chorionic villi sampling, amniocentesis, ultrasound, and various biomarkers including inhibins, alpha-fetoproteins, and human chorionic gonadotropin, in detecting aneuploidy, mosaicism, and Down syndrome? Additionally, what is the diagnostic value of specific markers such as nuchal translucency, nasal bone, and tricuspid regurgitation? Finally, what are the reproducibility of results, likelihood ratios, and reference values for these markers, and how do false positive and false negative reactions affect their sensitivity and specificity?", "What is the accuracy and reliability of prenatal diagnostic markers, such as chorionic villi sampling, amniocentesis, ultrasound, and various biomarkers including inhibins, alpha-fetoproteins, and human chorionic gonadotropin, in detecting aneuploidy, mosaicism, and Down syndrome? Additionally, what is the reproducibility of results, reference values, and diagnostic markers, such as nuchal translucency, nasal bone, and tricuspid regurgitation, used in detecting aneuploidy, mosaicism, and Down syndrome? Finally, what is the predictive value of prenatal diagnostic markers, such as chorionic villi sampling, amniocentesis, ultrasound, and various biomarkers including inhibins, alpha-fetoproteins, and human chorionic gonadotropin, for detecting aneuploidy, mosaicism, and Down syndrome?", "What is the accuracy and reliability of prenatal diagnostic markers, such as chorionic villi sampling, amniocentesis, ultrasound, and various biomarkers including inhibins, alpha-fetoproteins, and human chorionic gonadotropin, in detecting aneuploidy? Additionally, what is the predictive value of these markers, as measured by sensitivity, specificity, likelihood ratios, and area under the ROC curve, and what is the reproducibility of results? Finally, what is the diagnostic value of markers such as nuchal translucency, nasal bone, and tricuspid regurgitation?", "What is the accuracy and reliability of prenatal diagnostic markers, such as chorionic villi sampling, amniocentesis, ultrasound, and various biomarkers including inhibins, alpha-fetoproteins, and human chorionic gonadotropin, in detecting aneuploidy, mosaicism, and Down syndrome? Additionally, what is the predictive value of these markers, as measured by sensitivity, specificity, likelihood ratios, and area under the ROC curve, in detecting these conditions? Finally, what is the reproducibility of results, in terms of false positive and false negative reactions, and reference values, for these markers?"]}
